Genome-wide association study of Alzheimer's disease with psychotic symptoms
Psychotic symptoms occur in ∼40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We unde...
Saved in:
Published in | Molecular psychiatry Vol. 17; no. 12; pp. 1316 - 1327 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.12.2012
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Psychotic symptoms occur in ∼40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. In all, 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD–P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD+P to AD–P cases, and (2) AD+P cases with controls (GERAD1, ADRC only). Aside from the
apolipoprotein E
(
APOE
) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; ‘AD+PvAD–P’
P
=2.85 × 10
−7
; ‘AD+PvControls’
P
=1.11 × 10
−4
). SNPs upstream of
SLC2A9
(rs6834555,
P
=3.0 × 10
−7
) and within
VSNL1
(rs4038131,
P
=5.9 × 10
−7
) showed strongest evidence for association with AD+P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized. |
---|---|
AbstractList | Psychotic symptoms occur in ~40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD.Inall,1299AD cases with psychosis (AD + P), 735 AD cases without psychosis (AD-P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD + P to AD-P cases, and (2) AD + P cases with controls (GERAD1, ADRC only). Aside from the apolipoprotein E (APOE) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; 'AD + PvAD-P' P = 2.85 x [10.sup.-7];'AD + PvControls' P = 1.11 x [10.sup.-4]). SNPs upstream of SLC2A9 (rs6834555, P = 3.0 x [10.sup.-7])and within VSNL1 (rs4038131, P = 5.9 x [10.sup.-7]) showed strongest evidence for association with AD + P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized. Psychotic symptoms occur in ~40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD.Inall,1299AD cases with psychosis (AD + P), 735 AD cases without psychosis (AD-P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD + P to AD-P cases, and (2) AD + P cases with controls (GERAD1, ADRC only). Aside from the apolipoprotein E (APOE) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; 'AD + PvAD-P' P = 2.85 x [10.sup.-7];'AD + PvControls' P = 1.11 x [10.sup.-4]). SNPs upstream of SLC2A9 (rs6834555, P = 3.0 x [10.sup.-7])and within VSNL1 (rs4038131, P = 5.9 x [10.sup.-7]) showed strongest evidence for association with AD + P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized. Molecular Psychiatry (2012) 17, 1316-1327; doi: 10.1038/mp.2011.125; published online 18 October 2011 Keywords: Alzheimer's disease; psychosis; behavioural symptoms; genome-wide association study; genetic Psychotic symptoms occur in ~40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. In all, 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD-P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD+P to AD-P cases, and (2) AD+P cases with controls (GERAD1, ADRC only). Aside from the apolipoprotein E (APOE) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; 'AD+PvAD-P' P=2.85 × 10(-7); 'AD+PvControls' P=1.11 × 10(-4)). SNPs upstream of SLC2A9 (rs6834555, P=3.0 × 10(-7)) and within VSNL1 (rs4038131, P=5.9 × 10(-7)) showed strongest evidence for association with AD+P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized.Psychotic symptoms occur in ~40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. In all, 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD-P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD+P to AD-P cases, and (2) AD+P cases with controls (GERAD1, ADRC only). Aside from the apolipoprotein E (APOE) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; 'AD+PvAD-P' P=2.85 × 10(-7); 'AD+PvControls' P=1.11 × 10(-4)). SNPs upstream of SLC2A9 (rs6834555, P=3.0 × 10(-7)) and within VSNL1 (rs4038131, P=5.9 × 10(-7)) showed strongest evidence for association with AD+P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized. Psychotic symptoms occur in ~40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. In all, 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD-P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD+P to AD-P cases, and (2) AD+P cases with controls (GERAD1, ADRC only). Aside from the apolipoprotein E (APOE) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; 'AD+PvAD-P' P=2.85 × 10(-7); 'AD+PvControls' P=1.11 × 10(-4)). SNPs upstream of SLC2A9 (rs6834555, P=3.0 × 10(-7)) and within VSNL1 (rs4038131, P=5.9 × 10(-7)) showed strongest evidence for association with AD+P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized. Psychotic symptoms occur in approximately 40% of subjects with Alzheimer’s disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWAS) to identify loci that a) increase susceptibility to an AD and subsequent psychotic symptoms; or b) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD−P) and 5659 controls were drawn from GERAD1, the NIA-LOAD family study and the University of Pittsburgh ADRC GWAS. Unobserved genotypes were imputed to provide data on > 1.8 million SNPs. Analyses in each dataset were completed comparing a) AD+P to AD−P cases, and b) AD+P cases with controls (GERAD1, ADRC only). Aside from the APOE locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; ‘AD+PvAD−P’ P =2.85 × 10 −7 ; ‘AD+PvControls’ P =1.11 × 10 −4 ). SNPs upstream of SLC2A9 (rs6834555, P =3.0×10 −7 ) and within VSNL1 (rs4038131, P =5.9×10 −7 ) showed strongest evidence for association with AD+P when compared to controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterised. Psychotic symptoms occur in ∼40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. In all, 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD–P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD+P to AD–P cases, and (2) AD+P cases with controls (GERAD1, ADRC only). Aside from the apolipoprotein E (APOE) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; ‘AD+PvAD–P’ P=2.85 × 10−7; ‘AD+PvControls’ P=1.11 × 10−4). SNPs upstream of SLC2A9 (rs6834555, P=3.0 × 10−7) and within VSNL1 (rs4038131, P=5.9 × 10−7) showed strongest evidence for association with AD+P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized. Psychotic symptoms occur in approximately 40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWAS) to identify loci that a) increase susceptibility to an AD and subsequent psychotic symptoms; or b) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD-P) and 5659 controls were drawn from GERAD1, the NIA-LOAD family study and the University of Pittsburgh ADRC GWAS. Unobserved genotypes were imputed to provide data on > 1.8 million SNPs. Analyses in each dataset were completed comparing a) AD+P to AD-P cases, and b) AD+P cases with controls (GERAD1, ADRC only). Aside from the APOE locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; 'AD+PvAD-P' P=2.85 x 10-7; 'AD+PvControls' P=1.11 x 10-4). SNPs upstream of SLC2A9 (rs6834555, P=3.0x10-7) and within VSNL1 (rs4038131, P=5.9x10-7) showed strongest evidence for association with AD+P when compared to controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterised. Psychotic symptoms occur in similar to 40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. In all, 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD-P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD+P to AD-P cases, and (2) AD+P cases with controls (GERAD1, ADRC only). Aside from the apolipoprotein E (APOE) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; 'AD+PvAD-P' P=2.85 10 super(-7); 'AD+PvControls' P=1.11 10 super(-4)). SNPs upstream of SLC2A9 (rs6834555, P=3.0 10 super(-7)) and within VSNL1 (rs4038131, P=5.9 10 super(-7)) showed strongest evidence for association with AD+P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized. Psychotic symptoms occur in ∼40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. In all, 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD–P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD+P to AD–P cases, and (2) AD+P cases with controls (GERAD1, ADRC only). Aside from the apolipoprotein E ( APOE ) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; ‘AD+PvAD–P’ P =2.85 × 10 −7 ; ‘AD+PvControls’ P =1.11 × 10 −4 ). SNPs upstream of SLC2A9 (rs6834555, P =3.0 × 10 −7 ) and within VSNL1 (rs4038131, P =5.9 × 10 −7 ) showed strongest evidence for association with AD+P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized. |
Audience | Academic |
Author | Jones, N Passmore, P Jones, L Lynch, A Sims, R DeKosky, S T Priotsi, P Demirci, F Y Stretton, A Gurling, H Barmada, M M Lovestone, S Brayne, C Livingston, G Gerrish, A Lopez, O L Russo, G McQuillin, A Ivanov, D Abraham, R Mayeux, R Owen, M J Harold, D Johnston, J Lawlor, B Moskvina, V Sweet, R Chapman, J Kamboh, M I Klei, L O'Donovan, M C Hollingworth, P Craig, D McGuinness, B Lupton, M Bass, N J Williams, J Devlin, B Gill, M Holmans, P Holmes, C |
AuthorAffiliation | 2 Department of Psychiatry, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213, USA 3 Department of Neurology, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213, USA 6 Institute of Public Health, University of Cambridge, Cambridge, UK 15 University of Virginia School of Medicine, Charlottesville VA, 22908 USA 13 Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA 5 Department of Neuroscience, Institute of Psychiatry, Kings College, London, UK 14 Taub Institute and the Department of Neurology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032, USA 7 Mercer's Institute for Research on Aging, St. James Hospital and Trinity College, Dublin, Ireland 10 Department of Mental Health Sciences, University College London, UK 8 Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, UK 9 D |
AuthorAffiliation_xml | – name: 8 Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, UK – name: 1 Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, Department of Psychological Medicine and Neurology, School of Medicine, Cardiff University, Cardiff, UK – name: 2 Department of Psychiatry, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213, USA – name: 10 Department of Mental Health Sciences, University College London, UK – name: 15 University of Virginia School of Medicine, Charlottesville VA, 22908 USA – name: 14 Taub Institute and the Department of Neurology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032, USA – name: 4 VISN 4 Mental Illness Research, Education and Clinical Center (MIRECC), VA Pittsburgh Healthcare System, Pittsburgh, PA, 15206 USA – name: 7 Mercer's Institute for Research on Aging, St. James Hospital and Trinity College, Dublin, Ireland – name: 6 Institute of Public Health, University of Cambridge, Cambridge, UK – name: 5 Department of Neuroscience, Institute of Psychiatry, Kings College, London, UK – name: 9 Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, UK – name: 13 Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA – name: 3 Department of Neurology, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213, USA |
Author_xml | – sequence: 1 givenname: P surname: Hollingworth fullname: Hollingworth, P organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 2 givenname: R surname: Sweet fullname: Sweet, R email: SweetRA@upmc.edu organization: Department of Psychiatry, University of Pittsburgh, School of Medicine, Department of Neurology, University of Pittsburgh, School of Medicine, VISN 4 Mental Illness Research, Education and Clinical Center (MIRECC), VA Pittsburgh Healthcare System – sequence: 3 givenname: R surname: Sims fullname: Sims, R organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 4 givenname: D surname: Harold fullname: Harold, D organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 5 givenname: G surname: Russo fullname: Russo, G organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 6 givenname: R surname: Abraham fullname: Abraham, R organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 7 givenname: A surname: Stretton fullname: Stretton, A organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 8 givenname: N surname: Jones fullname: Jones, N organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 9 givenname: A surname: Gerrish fullname: Gerrish, A organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 10 givenname: J surname: Chapman fullname: Chapman, J organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 11 givenname: D surname: Ivanov fullname: Ivanov, D organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 12 givenname: V surname: Moskvina fullname: Moskvina, V organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 13 givenname: S surname: Lovestone fullname: Lovestone, S organization: Department of Neuroscience, Kings College London, Institute of Psychiatry – sequence: 14 givenname: P surname: Priotsi fullname: Priotsi, P organization: Department of Neuroscience, Kings College London, Institute of Psychiatry – sequence: 15 givenname: M surname: Lupton fullname: Lupton, M organization: Department of Neuroscience, Kings College London, Institute of Psychiatry – sequence: 16 givenname: C surname: Brayne fullname: Brayne, C organization: Institute of Public Health, University of Cambridge – sequence: 17 givenname: M surname: Gill fullname: Gill, M organization: Mercer's Institute for Research on Aging, St James Hospital and Trinity College – sequence: 18 givenname: B surname: Lawlor fullname: Lawlor, B organization: Mercer's Institute for Research on Aging, St James Hospital and Trinity College – sequence: 19 givenname: A surname: Lynch fullname: Lynch, A organization: Mercer's Institute for Research on Aging, St James Hospital and Trinity College – sequence: 20 givenname: D surname: Craig fullname: Craig, D organization: Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast – sequence: 21 givenname: B surname: McGuinness fullname: McGuinness, B organization: Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast – sequence: 22 givenname: J surname: Johnston fullname: Johnston, J organization: Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast – sequence: 23 givenname: C surname: Holmes fullname: Holmes, C organization: Division of Clinical Neurosciences, School of Medicine, University of Southampton – sequence: 24 givenname: G surname: Livingston fullname: Livingston, G organization: Department of Mental Health Sciences, University College London – sequence: 25 givenname: N J surname: Bass fullname: Bass, N J organization: Department of Mental Health Sciences, University College London – sequence: 26 givenname: H surname: Gurling fullname: Gurling, H organization: Department of Mental Health Sciences, University College London – sequence: 27 givenname: A surname: McQuillin fullname: McQuillin, A organization: Department of Mental Health Sciences, University College London – sequence: 30 givenname: P surname: Holmans fullname: Holmans, P organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 31 givenname: L surname: Jones fullname: Jones, L organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 32 givenname: B surname: Devlin fullname: Devlin, B organization: Department of Psychiatry, University of Pittsburgh, School of Medicine – sequence: 33 givenname: L surname: Klei fullname: Klei, L organization: Department of Psychiatry, University of Pittsburgh, School of Medicine – sequence: 34 givenname: M M surname: Barmada fullname: Barmada, M M organization: Taub Institute and the Department of Neurology, Columbia University, College of Physicians and Surgeons – sequence: 35 givenname: F Y surname: Demirci fullname: Demirci, F Y organization: Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh – sequence: 36 givenname: S T surname: DeKosky fullname: DeKosky, S T organization: Department of Neurology, University of Pittsburgh, School of Medicine, University of Virginia School of Medicine – sequence: 37 givenname: O L surname: Lopez fullname: Lopez, O L organization: Department of Neurology, University of Pittsburgh, School of Medicine – sequence: 38 givenname: P surname: Passmore fullname: Passmore, P organization: Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast – sequence: 39 givenname: M J surname: Owen fullname: Owen, M J organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 40 givenname: M C surname: O'Donovan fullname: O'Donovan, M C organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University – sequence: 41 givenname: R surname: Mayeux fullname: Mayeux, R organization: Taub Institute and the Department of Neurology, Columbia University, College of Physicians and Surgeons – sequence: 42 givenname: M I surname: Kamboh fullname: Kamboh, M I organization: Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh – sequence: 43 givenname: J surname: Williams fullname: Williams, J email: williamsj@cardiff.ac.uk organization: Department of Psychological Medicine and Neurology, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, School of Medicine, Cardiff University |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26664764$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22005930$$D View this record in MEDLINE/PubMed https://hal.science/hal-00688561$$DView record in HAL |
BookMark | eNqFkstv1DAQxiNURB9w4g6REAIEWez4EeeCtKqgRVqJC5wtx550XSV2aietlr8eR7tsH6pAPtia-c2MP_s7zg6cd5BlLzFaYETE535YlAjjBS7Zk-wI04oXjFXiIJ0JqwuKBT3MjmO8RGhOsmfZYVkixGqCjrLVGTjfQ3FjDeQqRq-tGq13eRwns8l9my-732uwPYR3MTc2goqQ39hxnQ9xo9d-tDqPm34YfR-fZ09b1UV4sdtPsl_fvv48PS9WP86-ny5Xhea8HAuNDJim5Q0IxLVRlWhbTEqBmABSM1yrxiDaNIgnfZwRLLRijakFpNsb4OQk-7LtO0xND0aDG4Pq5BBsr8JGemXl_Yyza3nhryUpq5ISlhp82DZYPyg7X67kHEOIC8E4vsaJfb8bFvzVBHGUvY0auk458FOUuKwIqSqUtv-jrKooFUQk9M0D9NJPwaVXkyWnLAlN6L8ojCshakYpv6UuVAfSutYn0XoeLZcEY0QFxyRRi0eotAz0VidLtTbF7xV83Bbo4GMM0O5fCiM5O0_2g5ydN-tK9Ku7f7Jn_1otAW93gIpadW1QTtt4y3HOkztp4j5tuZhS7gLCHc2Pzn29xZ0apwD7fv0wIzPxB9KX-CI |
CitedBy_id | crossref_primary_10_7717_peerj_17339 crossref_primary_10_1007_s00406_022_01432_6 crossref_primary_10_1016_j_neulet_2019_03_050 crossref_primary_10_1038_s41380_018_0055_z crossref_primary_10_1038_s41380_021_01152_8 crossref_primary_10_1089_gtmb_2012_0253 crossref_primary_10_1371_journal_pone_0103851 crossref_primary_10_1177_1533317516679303 crossref_primary_10_1016_j_schres_2018_12_010 crossref_primary_10_3390_cells9122642 crossref_primary_10_1016_j_jagp_2012_10_028 crossref_primary_10_1016_j_jalz_2016_02_010 crossref_primary_10_1111_jnc_12261 crossref_primary_10_18632_aging_203321 crossref_primary_10_1016_j_nepig_2016_05_001 crossref_primary_10_1186_1744_9081_8_62 crossref_primary_10_1001_jamaneurol_2024_0586 crossref_primary_10_1016_j_gene_2020_144975 crossref_primary_10_1016_S2215_0366_16_00021_3 crossref_primary_10_1111_age_12174 crossref_primary_10_1186_s13195_018_0458_8 crossref_primary_10_1038_s41398_019_0592_5 crossref_primary_10_3389_fncel_2018_00473 crossref_primary_10_3233_JAD_210685 crossref_primary_10_1007_s11910_015_0531_7 crossref_primary_10_1016_j_neurobiolaging_2015_08_006 crossref_primary_10_1080_01616412_2020_1782130 crossref_primary_10_1093_brain_awab028 crossref_primary_10_1097_MD_0000000000001742 crossref_primary_10_1038_tp_2015_42 crossref_primary_10_1016_j_brainres_2015_10_005 crossref_primary_10_3233_JAD_170062 crossref_primary_10_1017_S1041610223000157 crossref_primary_10_1007_s12264_016_0011_3 crossref_primary_10_1016_j_biopsych_2013_08_020 crossref_primary_10_1186_1742_2094_11_25 crossref_primary_10_3389_fphys_2019_01323 crossref_primary_10_1002_jnr_23373 crossref_primary_10_1007_s12551_021_00903_9 crossref_primary_10_3390_genes12121990 crossref_primary_10_3233_JHD_170277 crossref_primary_10_1007_s00401_012_0996_2 crossref_primary_10_1007_s11910_020_01074_y crossref_primary_10_1002_cbin_11106 crossref_primary_10_1016_j_expneurol_2019_113095 crossref_primary_10_1007_s40142_014_0030_1 crossref_primary_10_1002_ajmg_b_32413 crossref_primary_10_3233_JAD_221247 crossref_primary_10_1111_ggi_13059 crossref_primary_10_1016_j_paid_2020_110498 crossref_primary_10_1016_j_xgen_2024_100506 crossref_primary_10_1038_mp_2017_81 crossref_primary_10_3389_fnins_2022_1060111 crossref_primary_10_3389_fnagi_2022_866886 crossref_primary_10_29001_2073_8552_2021_36_4_37_44 crossref_primary_10_1002_ajmg_a_62524 crossref_primary_10_1016_j_neurobiolaging_2020_02_018 crossref_primary_10_1002_ajmg_b_32684 crossref_primary_10_1038_s41593_020_0599_5 crossref_primary_10_3233_JAD_150705 crossref_primary_10_1016_j_neurobiolaging_2014_03_003 crossref_primary_10_1007_s11910_012_0296_1 crossref_primary_10_1016_j_brainresbull_2012_02_010 crossref_primary_10_1007_s10654_020_00633_4 crossref_primary_10_1038_tp_2015_64 crossref_primary_10_1007_s40473_016_0095_0 crossref_primary_10_1002_ajmg_b_32516 crossref_primary_10_1152_physrev_00035_2018 crossref_primary_10_3390_ijms25042211 crossref_primary_10_1111_nan_12183 crossref_primary_10_1002_hbm_22494 crossref_primary_10_1007_s00702_013_1091_0 crossref_primary_10_1186_s13195_014_0090_1 crossref_primary_10_1371_journal_pone_0111462 crossref_primary_10_1038_nrneurol_2012_135 crossref_primary_10_1002_alz_12514 crossref_primary_10_1016_j_jalz_2015_02_006 crossref_primary_10_1111_tra_12547 crossref_primary_10_1016_j_gene_2018_06_011 crossref_primary_10_1016_j_imu_2020_100439 crossref_primary_10_18632_aging_101515 crossref_primary_10_1007_s11011_021_00754_z crossref_primary_10_3389_fnagi_2021_646901 crossref_primary_10_1002_trc2_12257 crossref_primary_10_3233_JAD_215107 crossref_primary_10_1097_MD_0000000000038076 crossref_primary_10_3389_fpsyt_2015_00030 |
Cites_doi | 10.1186/1423-0127-17-2 10.1001/archgenpsychiatry.2010.196 10.1016/j.neurobiolaging.2010.10.003 10.1002/ajmg.b.30549 10.1038/ng.201 10.1007/s00702-008-0156-y 10.1038/ng.440 10.1017/S1041610209991001 10.1038/ng.209 10.1097/00019442-200506000-00005 10.1016/S0165-1781(98)00051-1 10.1002/ajmg.b.30515 10.3233/JAD-2010-1274 10.1038/ng1847 10.1111/j.0006-341X.1999.00997.x 10.1093/hmg/ddn246 10.1093/brain/awq001 10.1038/ng.803 10.1097/00019442-200507000-00011 10.1017/S1041610208007734 10.1086/519795 10.1016/0022-3956(75)90026-6 10.1016/S0140-6736(09)60072-6 10.1001/archneurol.2010.201 10.1111/j.1532-5415.2006.00854.x 10.1093/hmg/ddn005 10.1176/appi.ajp.162.11.2022 10.1111/j.1420-9101.2005.00917.x 10.1007/s10620-006-9102-8 10.1016/j.ajhg.2011.01.017 10.1093/rheumatology/keq425 10.1001/archneurol.2010.108 10.1002/gepi.20541 10.1016/j.brainres.2010.06.018 10.1001/archneur.56.10.1266 10.1371/journal.pgen.1001308 10.1176/ajp.152.9.1349 10.3233/JAD-2010-1330 10.1093/schbul/sbp020 10.1007/s00441-008-0716-3 10.1001/jama.2010.574 10.1212/WNL.58.6.907 10.1111/j.1529-8817.2005.00175.x 10.1001/archneurol.2010.147 10.1038/ng.106 10.1016/S0920-9964(02)00407-3 10.1038/ng.801 10.1038/sj.mp.4001262 10.1212/WNL.54.5.1109 10.1093/bioinformatics/btq340 10.1212/WNL.34.7.939 10.1093/hmg/ddq221 10.1001/archneur.65.11.1518 10.1373/clinchem.2008.104497 10.1176/ajp.139.9.1136 10.1212/WNL.44.12.2308 10.1212/WNL.41.4.479 10.1038/nature08494 10.1212/WNL.48.5_Suppl_6.10S 10.1038/ng.523 10.1002/gps.2628 10.1007/s00439-009-0703-0 10.1038/ng.439 10.1038/mp.2011.135 10.1038/nature08186 10.1038/nature08185 10.1038/nature08192 10.1016/j.neurobiolaging.2011.06.016 |
ContentType | Journal Article |
Contributor | Gaskel, Peter Morgan, Kevin Heuser, Isabella Hyman, Bradley T Rossor, Martin Kornhuber, Johannes Sims, Rebecca Gurling, Hugh Moskvina, Valentina Collinge, John Williamson, Jennifer Heun, Reiner Kowall, Neil Fox, Nick Mead, Simon Green, Robert Wiltfang, Jens Hamshere, Marian Mühleisen, Thomas W O'Donovan, Michael Morris, John C Maier, Wolfgang Moebus, Susanne Shaw, Christopher E Nöthen, Markus M Thomas, Charlene Gwilliam, Rhian Morgan, Angharad Bass, Nicholas J Dowzell, Kimberley Schmechel, Donald Hampel, Harald Owen, Michael J Carrasquillo, Minerva M Kuntz, Karen Lupton, Michelle K Kölsch, Heike Dichgans, Martin Guerreiro, Rita Mayo, Kevin Hüll, Michael Blacker, Deborah Wichmann, H-Erich Brown, Kristelle Klopp, Norman McGuinness, Bernadette Rujescu, Dan Goate, Alison Younkin, Steven G Hardy, John Growdon, John H Holmans, Peter Cruchaga, Carlos Nowotny, Petra van den Bussche, Hendrik Farlow, Martin R Boeve, Bradley Proitsi, Petroula Passmore, Peter Santana, Vincent Farrer, Lindsay Powell, John Jones, Nicola Horner, Kelly Lawlor, Brian Lynch, Aoibhinn |
Contributor_xml | – sequence: 1 givenname: Denise surname: Harold fullname: Harold, Denise – sequence: 2 givenname: Richard surname: Abraham fullname: Abraham, Richard – sequence: 3 givenname: Paul surname: Hollingworth fullname: Hollingworth, Paul – sequence: 4 givenname: Rebecca surname: Sims fullname: Sims, Rebecca – sequence: 5 givenname: Amy surname: Gerrish fullname: Gerrish, Amy – sequence: 6 givenname: Marian surname: Hamshere fullname: Hamshere, Marian – sequence: 7 givenname: Jaspreet Singh surname: Pahwa fullname: Pahwa, Jaspreet Singh – sequence: 8 givenname: Valentina surname: Moskvina fullname: Moskvina, Valentina – sequence: 9 givenname: Kimberley surname: Dowzell fullname: Dowzell, Kimberley – sequence: 10 givenname: Amy surname: Williams fullname: Williams, Amy – sequence: 11 givenname: Nicola surname: Jones fullname: Jones, Nicola – sequence: 12 givenname: Charlene surname: Thomas fullname: Thomas, Charlene – sequence: 13 givenname: Alexandra surname: Stretton fullname: Stretton, Alexandra – sequence: 14 givenname: Angharad surname: Morgan fullname: Morgan, Angharad – sequence: 15 givenname: Simon surname: Lovestone fullname: Lovestone, Simon – sequence: 16 givenname: John surname: Powell fullname: Powell, John – sequence: 17 givenname: Petroula surname: Proitsi fullname: Proitsi, Petroula – sequence: 18 givenname: Michelle K surname: Lupton fullname: Lupton, Michelle K – sequence: 19 givenname: Carol surname: Brayne fullname: Brayne, Carol – sequence: 20 givenname: David C surname: Rubinsztein fullname: Rubinsztein, David C – sequence: 21 givenname: Michael surname: Gill fullname: Gill, Michael – sequence: 22 givenname: Brian surname: Lawlor fullname: Lawlor, Brian – sequence: 23 givenname: Aoibhinn surname: Lynch fullname: Lynch, Aoibhinn – sequence: 24 givenname: Kevin surname: Morgan fullname: Morgan, Kevin – sequence: 25 givenname: Kristelle surname: Brown fullname: Brown, Kristelle – sequence: 26 givenname: Peter surname: Passmore fullname: Passmore, Peter – sequence: 27 givenname: David surname: Craig fullname: Craig, David – sequence: 28 givenname: Bernadette surname: McGuinness fullname: McGuinness, Bernadette – sequence: 29 givenname: Stephen surname: Todd fullname: Todd, Stephen – sequence: 30 givenname: Janet surname: Johnston fullname: Johnston, Janet – sequence: 31 givenname: Clive surname: Holmes fullname: Holmes, Clive – sequence: 32 givenname: David surname: Mann fullname: Mann, David – sequence: 33 givenname: A David surname: Smith fullname: Smith, A David – sequence: 34 givenname: Seth surname: Love fullname: Love, Seth – sequence: 35 givenname: Patrick G surname: Kehoe fullname: Kehoe, Patrick G – sequence: 36 givenname: John surname: Hardy fullname: Hardy, John – sequence: 37 givenname: Simon surname: Mead fullname: Mead, Simon – sequence: 38 givenname: Nick surname: Fox fullname: Fox, Nick – sequence: 39 givenname: Martin surname: Rossor fullname: Rossor, Martin – sequence: 40 givenname: John surname: Collinge fullname: Collinge, John – sequence: 41 givenname: Wolfgang surname: Maier fullname: Maier, Wolfgang – sequence: 42 givenname: Frank surname: Jessen fullname: Jessen, Frank – sequence: 43 givenname: Reiner surname: Heun fullname: Heun, Reiner – sequence: 44 givenname: Heike surname: Kölsch fullname: Kölsch, Heike – sequence: 45 givenname: Britta surname: Schürmann fullname: Schürmann, Britta – sequence: 46 givenname: Hendrik surname: van den Bussche fullname: van den Bussche, Hendrik – sequence: 47 givenname: Isabella surname: Heuser fullname: Heuser, Isabella – sequence: 48 givenname: Johannes surname: Kornhuber fullname: Kornhuber, Johannes – sequence: 49 givenname: Jens surname: Wiltfang fullname: Wiltfang, Jens – sequence: 50 givenname: Martin surname: Dichgans fullname: Dichgans, Martin – sequence: 51 givenname: Lutz surname: Frölich fullname: Frölich, Lutz – sequence: 52 givenname: Harald surname: Hampel fullname: Hampel, Harald – sequence: 53 givenname: Michael surname: Hüll fullname: Hüll, Michael – sequence: 54 givenname: Dan surname: Rujescu fullname: Rujescu, Dan – sequence: 55 givenname: Alison surname: Goate fullname: Goate, Alison – sequence: 56 givenname: John S K surname: Kauwe fullname: Kauwe, John S K – sequence: 57 givenname: Carlos surname: Cruchaga fullname: Cruchaga, Carlos – sequence: 58 givenname: Petra surname: Nowotny fullname: Nowotny, Petra – sequence: 59 givenname: John C surname: Morris fullname: Morris, John C – sequence: 60 givenname: Kevin surname: Mayo fullname: Mayo, Kevin – sequence: 61 givenname: Gill surname: Livingston fullname: Livingston, Gill – sequence: 62 givenname: Nicholas J surname: Bass fullname: Bass, Nicholas J – sequence: 63 givenname: Hugh surname: Gurling fullname: Gurling, Hugh – sequence: 64 givenname: Andrew surname: McQuillin fullname: McQuillin, Andrew – sequence: 65 givenname: Rhian surname: Gwilliam fullname: Gwilliam, Rhian – sequence: 66 givenname: Panagiotis surname: Deloukas fullname: Deloukas, Panagiotis – sequence: 67 givenname: Ammar surname: Al-Chalabi fullname: Al-Chalabi, Ammar – sequence: 68 givenname: Christopher E surname: Shaw fullname: Shaw, Christopher E – sequence: 69 givenname: Andrew B surname: Singleton fullname: Singleton, Andrew B – sequence: 70 givenname: Rita surname: Guerreiro fullname: Guerreiro, Rita – sequence: 71 givenname: Thomas W surname: Mühleisen fullname: Mühleisen, Thomas W – sequence: 72 givenname: Markus M surname: Nöthen fullname: Nöthen, Markus M – sequence: 73 givenname: Susanne surname: Moebus fullname: Moebus, Susanne – sequence: 74 givenname: Karl-Heinz surname: Jöckel fullname: Jöckel, Karl-Heinz – sequence: 75 givenname: Norman surname: Klopp fullname: Klopp, Norman – sequence: 76 givenname: H-Erich surname: Wichmann fullname: Wichmann, H-Erich – sequence: 77 givenname: Minerva M surname: Carrasquillo fullname: Carrasquillo, Minerva M – sequence: 78 givenname: V Shane surname: Pankratz fullname: Pankratz, V Shane – sequence: 79 givenname: Steven G surname: Younkin fullname: Younkin, Steven G – sequence: 80 givenname: Peter surname: Holmans fullname: Holmans, Peter – sequence: 81 givenname: Michael surname: O'Donovan fullname: O'Donovan, Michael – sequence: 82 givenname: Michael J surname: Owen fullname: Owen, Michael J – sequence: 83 givenname: Julie surname: Williams fullname: Williams, Julie – sequence: 84 givenname: Robert surname: Green fullname: Green, Robert – sequence: 85 givenname: Neil surname: Kowall fullname: Kowall, Neil – sequence: 86 givenname: Lindsay surname: Farrer fullname: Farrer, Lindsay – sequence: 87 givenname: Jennifer surname: Williamson fullname: Williamson, Jennifer – sequence: 88 givenname: Vincent surname: Santana fullname: Santana, Vincent – sequence: 89 givenname: Donald surname: Schmechel fullname: Schmechel, Donald – sequence: 90 givenname: Peter surname: Gaskel fullname: Gaskel, Peter – sequence: 91 givenname: Bernardino surname: Ghetti fullname: Ghetti, Bernardino – sequence: 92 givenname: Martin R surname: Farlow fullname: Farlow, Martin R – sequence: 93 givenname: Kelly surname: Horner fullname: Horner, Kelly – sequence: 94 givenname: John H surname: Growdon fullname: Growdon, John H – sequence: 95 givenname: Deborah surname: Blacker fullname: Blacker, Deborah – sequence: 96 givenname: Rudolph E surname: Tanzi fullname: Tanzi, Rudolph E – sequence: 97 givenname: Bradley T surname: Hyman fullname: Hyman, Bradley T – sequence: 98 givenname: Bradley surname: Boeve fullname: Boeve, Bradley – sequence: 99 givenname: Karen surname: Kuntz fullname: Kuntz, Karen – sequence: 100 givenname: Lindsay surname: Norgaard fullname: Norgaard, Lindsay |
Copyright | Macmillan Publishers Limited 2012 2015 INIST-CNRS COPYRIGHT 2012 Nature Publishing Group Copyright Nature Publishing Group Dec 2012 Macmillan Publishers Limited 2012. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: Macmillan Publishers Limited 2012 – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2012 Nature Publishing Group – notice: Copyright Nature Publishing Group Dec 2012 – notice: Macmillan Publishers Limited 2012. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
CorporateAuthor | National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group GERAD Consortium the GERAD Consortium the National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group |
CorporateAuthor_xml | – sequence: 0 name: the National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group – sequence: 0 name: the GERAD Consortium – name: National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group – name: GERAD Consortium |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PQEST PQQKQ PQUKI PSYQQ Q9U 7X8 1XC VOOES 5PM |
DOI | 10.1038/mp.2011.125 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Psychology Database Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest One Psychology ProQuest One Psychology MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology Medicine Public Health |
EISSN | 1476-5578 |
EndPage | 1327 |
ExternalDocumentID | oai_HAL_hal_00688561v1 2821042671 A311048613 10_1038_mp_2011_125 22005930 26664764 mp2011125 |
Genre | Multicenter Study Meta-Analysis Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States United Kingdom United Kingdom--UK United States--US Pittsburgh Pennsylvania |
GeographicLocations_xml | – name: United Kingdom – name: United States – name: United Kingdom--UK – name: United States--US – name: Pittsburgh Pennsylvania |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: P30 AG028377 – fundername: NIA NIH HHS grantid: P50AG165574 – fundername: NIA NIH HHS grantid: P01AG05138 – fundername: NIA NIH HHS grantid: P01 AG002219 – fundername: NIA NIH HHS grantid: P50 AG005136 – fundername: NIA NIH HHS grantid: P50 AG008702 – fundername: NIA NIH HHS grantid: P50 AG005681 – fundername: NIA NIH HHS grantid: P01AG02219 – fundername: NIA NIH HHS grantid: P30 AG008017 – fundername: Medical Research Council grantid: G0800509 – fundername: National Institute on Aging : NIA grantid: R01 AG027224-04 || AG – fundername: National Institute on Aging : NIA grantid: R01 AG030653-04 || AG – fundername: National Institute on Aging : NIA grantid: P50 AG005133-23 || AG |
GroupedDBID | - -Q- 0R 123 29M 2WC 39C 3V. 4.4 53G 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AADWK AAPBV AAWBL AAYJO AAZLF ABAWZ ABDBF ABDEU ABFLS ABGIJ ABIVO ABPTK ABUWG ACGFS ACKTT ACPRK ADACO ADBBV ADHDB ADQMX AEDAW AEJRE AENEX AEXYK AFKRA AFRAH AFSHS AGEZK AHMBA AHSBF AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AXYYD AZQEC B0M BAWUL BBAFP BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG COF CS3 DIK DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EPL EPS ESX F5P FDQFY FEDTE FERAY FIZPM FSGXE FYUFA GNUQQ HCIFZ HVGLF HZ IAO IHR INH INR IPY ITC JSO KQ8 M1P M2M M7P NAO O9- OK1 OVD P2P PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q- Q2X RIG RNS RNT RNTTT SNX SNYQT SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS W2D ZA5 --- 0R~ 36B 406 AACDK AANZL AASML AATNV ABAKF ABJNI ABLJU ABZZP ACAOD ACRQY ACZOJ AEFQL AEMSY AEVLU AFBBN AGAYW AGHAI AGQEE AIGIU AILAN ALIPV AMYLF CCPQU DNIVK DPUIP EMOBN FIGPU HMCUK HZ~ IWAJR JZLTJ NQJWS PSYQQ SOHCF SRMVM UKHRP ~8M ACBMV ACBRV ACBYP ACIGE ACTTH ACVWB ADMDM ADYYL AEFTE AFNRJ AGGBP AJCLW AJDOV IQODW AAYZH CGR CUY CVF ECM EIF NPM ROL AAYXX CITATION 7TK 7XB 8FE 8FH 8FK K9. LK8 Q9U 7X8 1XC VOOES 5PM |
ID | FETCH-LOGICAL-c662t-c0dedbf6be806cda78ff1328058e39519abd04bb0610365318ca5bd98e765de63 |
IEDL.DBID | 7X7 |
ISSN | 1359-4184 1476-5578 |
IngestDate | Tue Sep 17 21:21:59 EDT 2024 Tue Oct 15 15:46:24 EDT 2024 Sat Oct 26 04:40:07 EDT 2024 Thu Oct 24 23:13:22 EDT 2024 Wed Dec 11 11:28:07 EST 2024 Thu Oct 10 22:01:20 EDT 2024 Tue Nov 19 21:15:34 EST 2024 Tue Nov 12 23:14:19 EST 2024 Fri Dec 06 00:43:08 EST 2024 Sat Nov 02 12:29:25 EDT 2024 Wed May 29 03:57:17 EDT 2024 Fri Oct 11 20:47:14 EDT 2024 Thu Oct 07 19:31:51 EDT 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | genetic behavioural symptoms Alzheimer's disease psychosis genome-wide association study Nervous system diseases Alzheimer disease Cerebral disorder Behavioral disorder Psychosis Symptomatology Central nervous system disease Genetics Degenerative disease |
Language | English |
License | CC BY 4.0 Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c662t-c0dedbf6be806cda78ff1328058e39519abd04bb0610365318ca5bd98e765de63 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 These authors contributed equally to this work Data used in the preparation of this article were obtained from the National Institute on Aging Late-Onset Alzheimer’s disease Family Study Group (NIA-LOAD). As such, the investigators within the NIA-LOAD consortium contributed to the design and implementation of NIA-LOAD and/or provided data but did not participate in analysis or writing of this report. See supplementary content for members of the NIA-LOAD consortium. Data used in the preparation of this article were obtained from the Genetic and Environmental Risk in Alzheimer’s disease GWAS (GERAD) genome-wide association study(2). As such, the investigators within the GERAD consortium contributed to the design and implementation of GERAD and/or provided data but did not participate in analysis or writing of this report. See supplementary content for members of the GERAD consortium. |
ORCID | 0000-0001-5307-663X 0000-0003-1567-2240 |
OpenAccessLink | https://hal.science/hal-00688561 |
PMID | 22005930 |
PQID | 1178895446 |
PQPubID | 44096 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3272435 hal_primary_oai_HAL_hal_00688561v1 proquest_miscellaneous_1273377027 proquest_miscellaneous_1257744838 proquest_journals_2645765577 proquest_journals_1178895446 gale_infotracmisc_A311048613 gale_infotracacademiconefile_A311048613 crossref_primary_10_1038_mp_2011_125 pubmed_primary_22005930 pascalfrancis_primary_26664764 springer_journals_10_1038_mp_2011_125 nature_primary_mp2011125 |
ProviderPackageCode | ABDEU AEDAW AAZLF -Q- AADWK AAYJO 70F ADQMX EE. RNTTT SWTZT ABGIJ RNT NAO |
PublicationCentury | 2000 |
PublicationDate | 2012-12-01 |
PublicationDateYYYYMMDD | 2012-12-01 |
PublicationDate_xml | – month: 12 year: 2012 text: 2012-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Basingstoke – name: England – name: New York |
PublicationTitle | Molecular psychiatry |
PublicationTitleAbbrev | Mol Psychiatry |
PublicationTitleAlternate | Mol Psychiatry |
PublicationYear | 2012 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – sequence: 0 name: Nature Publishing Group – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Lee, CH, Liu, CM, Wen, CC, Chang, SM, Hwu, HG 2010; 17 Reisberg, B, Ferris, SH, de Leon, MJ, Crook, T 1982; 139 Moskvina, V, Holmans, P, Schmidt, KM, Craddock, N 2005; 69 Harold, D, Abraham, R, Hollingworth, P, Sims, R, Gerrish, A, Hamshere, ML 2009; 41 Lichtenstein, P, Yip, BH, Bjork, C, Pawitan, Y, Cannon, TD, Sullivan, PF 2009; 373 Hollingworth, P, Hamshere, ML, Moskvina, V, Dowzell, K, Moore, PJ, Foy, C 2006; 54 Cummings, JL 1997; 48 Shin, IS, Carter, M, Masterman, D, Fairbanks, L, Cummings, JL 2005; 13 Hollingworth, P, Harold, D, Sims, R, Gerrish, A, Lambert, JC, Carrasquillo, MM 2011; 43 McKhann, G, Drachman, D, Folstein, M, Katzman, R, Price, D, Stadlan, EM 1984; 34 Tariot, PN, Mack, JL, Patterson, MB, Edland, SD, Weiner, MF, Fillenbaum, G 1995; 152 Lee, AB, Luca, D, Klei, L, Devlin, B, Roeder, K 2010; 34 Whitlock, MC 2005; 18 Lee, JM, Blennow, K, Andreasen, N, Laterza, O, Modur, V, Olander, J 2008; 54 Kamboh, MI, Minster, RL, Demirci, FY, Ganguli, M, Dekosky, ST, Lopez, OL 2010 Price, AL, Patterson, NJ, Plenge, RM, Weinblatt, ME, Shadick, NA, Reich, D 2006; 38 Weamer, EA, Emanuel, JE, Varon, D, Miyahara, S, Wilkosz, PA, Lopez, OL 2009; 21 Yao, JK, Reddy, R, van Kammen, DP 1998; 80 Craddock, N, O'Donovan, MC, Owen, MJ 2009; 35 Ganguli, M, Dodge, HH, Chen, P, Belle, S, DeKosky, ST 2000; 54 Biffi, A, Anderson, CD, Desikan, RS, Sabuncu, M, Cortellini, L, Schmansky, N 2010; 67 Lopez, OL, Wisniewski, SR, Becker, JT, Boller, F, DeKosky, ST 1999; 56 Willer, CJ, Li, Y, Abecasis, GR 2010; 26 Vitart, V, Rudan, I, Hayward, C, Gray, NK, Floyd, J, Palmer, CN 2008; 40 Lee, JH, Cheng, R, Graff-Radford, N, Foroud, T, Mayeux, R 2008; 65 Chu, SH, Roeder, K, Ferrell, RE, Devlin, B, DeMichele-Sweet, MA, Kamboh, MI 2011 Schjeide, BM, Schnack, C, Lambert, JC, Lill, CM, Kirchheiner, J, Tumani, H 2011; 68 Lambert, JC, Heath, S, Even, G, Campion, D, Sleegers, K, Hiltunen, M 2009; 41 Ferreira, MA, O'Donovan, MC, Meng, YA, Jones, IR, Ruderfer, DM, Jones, L 2008; 40 Carrasquillo, MM, Belbin, O, Hunter, TA, Ma, L, Bisceglio, GD, Zou, F 2010; 67 Cummings, JL, Mega, M, Gray, K, Rosenberg-Thompson, S, Carusi, DA, Gornbein, J 1994; 44 Lettre, G, Rioux, JD 2008; 17 Berg, L 1988; 24 Sweet, RA, Nimgaonkar, VL, Devlin, B, Lopez, OL, DeKosky, ST 2002; 58 Manolio, TA, Collins, FS, Cox, NJ, Goldstein, DB, Hindorff, LA, Hunter, DJ 2009; 461 O'Donovan, MC, Craddock, NJ, Owen, MJ 2009; 126 O'Donovan, MC, Craddock, N, Norton, N, Williams, H, Peirce, T, Moskvina, V 2008; 40 Kam, M, Massare, J, Gallinger, S, Kinzie, J, Weaver, D, Dingell, JD 2006; 51 Seshadri, S, Fitzpatrick, AL, Ikram, MA, DeStefano, AL, Gudnason, V, Boada, M 2010; 303 Ropacki, SA, Jeste, DV 2005; 162 Demichele-Sweet, MA, Lopez, OL, Sweet, RA 2011; 2011 Demichele-Sweet, MA, Kleia, L, Devlin, B, Ferrellb, RE, Weamera, EA, Emanuela, JE 2011; 32 Bacanu, SA, Devlin, B, Chowdari, KV, DeKosky, ST, Nimgaonkar, VL, Sweet, RA 2005; 13 Lopez, OL, DeKosky, ST 2003; 37 Sweet, RA, Bennett, DA, Graff-Radford, NR, Mayeux, R 2010; 133 Martins-de-Souza, D, Gattaz, WF, Schmitt, A, Rewerts, C, Marangoni, S, Novello, JC 2009; 116 Devlin, B, Roeder, K 1999; 55 Purcell, SM, Wray, NR, Stone, JL, Visscher, PM, O'Donovan, MC, Sullivan, PF 2009; 460 Hollingworth, P, Harold, D, Jones, L, Owen, MJ, Williams, J 2011; 26 Cichon, S, Muhleisen, TW, Degenhardt, FA, Mattheisen, M, Miro, X, Strohmaier, J 2011; 88 Shi, J, Levinson, DF, Duan, J, Sanders, AR, Zheng, Y, Pe'er, I 2009; 460 Beveridge, NJ, Tooney, PA, Carroll, AP, Gardiner, E, Bowden, N, Scott, RJ 2008; 17 Sweet, RA, Nimgaonkar, VL, Devlin, B, Jeste, DV 2003; 8 Wilkosz, PA, Kodavali, C, Weamer, EA, Miyahara, S, Lopez, OL, Nimgaonkar, VL 2007; 144B Zhang, Q, Yu, JT, Zhu, QX, Zhang, W, Wu, ZC, Miao, D 2010; 1348 Corneveaux, JJ, Myers, AJ, Allen, AN, Pruzin, JJ, Ramirez, M, Engel, A 2010; 19 Wilkosz, PA, Seltman, HJ, Devlin, B, Weamer, EA, Lopez, OL, Dekosky, ST 2010; 22 Folstein, MF, Folstein, SE, McHugh, PR 1975; 12 Hollingworth, P, Hamshere, ML, Holmans, PA, O'Donovan, MC, Sims, R, Powell, J 2007; 144B Wijsman, EM, Pankratz, ND, Choi, Y, Rothstein, JH, Faber, KM, Cheng, R 2011; 7 McMahon, FJ, Akula, N, Schulze, TG, Muglia, P, Tozzi, F, Detera-Wadleigh, SD 2010; 42 Mirra, SS, Heyman, A, McKeel, D, Sumi, SM, Crain, BJ, Brownlee, LM 1991; 41 Rule, AD, de Andrade, M, Matsumoto, M, Mosley, TH, Kardia, S, Turner, ST 2011; 50 Reddy, R, Keshavan, M, Yao, JK 2003; 62 Purcell, S, Neale, B, Todd-Brown, K, Thomas, L, Ferreira, MA, Bender, D 2007; 81 Stefansson, H, Ophoff, RA, Steinberg, S, Andreassen, OA, Cichon, S, Rujescu, D 2009; 460 Naj, AC, Jun, G, Beecham, GW, Wang, LS, Vardarajan, BN, Buros, J 2011; 43 DeMichele-Sweet, MA, Sweet, RA 2010; 19 Kamboh, MI, Barmada, MM, Demirci, FY, Minster, RL, Carrasquillo, MM, Pankratz, VS 2011 Braunewell, KH, Klein-Szanto, AJ 2009; 335 Jun, G, Naj, AC, Beecham, GW, Wang, LS, Buros, J, Gallins, PJ 2010; 67 Bowman, GL, Shannon, J, Frei, B, Kaye, JA, Quinn, JF 2010; 19 Berg (CR37) 1988; 24 Devlin, Roeder (CR44) 1999; 55 McMahon, Akula, Schulze, Muglia, Tozzi, Detera-Wadleigh (CR49) 2010; 42 Harold, Abraham, Hollingworth, Sims, Gerrish, Hamshere (CR2) 2009; 41 Ropacki, Jeste (CR14) 2005; 162 CR39 Lopez, DeKosky (CR29) 2003; 37 Hollingworth, Hamshere, Holmans, O’Donovan, Sims, Powell (CR18) 2007; 144B Lee, Liu, Wen, Chang, Hwu (CR63) 2010; 17 Ferreira, O’Donovan, Meng, Jones, Ruderfer, Jones (CR48) 2008; 40 Wilkosz, Seltman, Devlin, Weamer, Lopez, Dekosky (CR16) 2010; 22 Wijsman, Pankratz, Choi, Rothstein, Faber, Cheng (CR23) 2011; 7 O’Donovan, Craddock, Norton, Williams, Peirce, Moskvina (CR47) 2008; 40 Kam, Massare, Gallinger, Kinzie, Weaver, Dingell (CR62) 2006; 51 DeMichele-Sweet, Sweet (CR22) 2010; 19 Lee, Blennow, Andreasen, Laterza, Modur, Olander (CR54) 2008; 54 CR71 Hollingworth, Harold, Sims, Gerrish, Lambert, Carrasquillo (CR9) 2011; 43 Cummings (CR32) 1997; 48 Craddock, O’Donovan, Owen (CR69) 2009; 35 Moskvina, Holmans, Schmidt, Craddock (CR70) 2005; 69 Cummings, Mega, Gray, Rosenberg-Thompson, Carusi, Gornbein (CR31) 1994; 44 Shi, Levinson, Duan, Sanders, Zheng, Pe’er (CR51) 2009; 460 Seshadri, Fitzpatrick, Ikram, DeStefano, Gudnason, Boada (CR8) 2010; 303 Whitlock (CR52) 2005; 18 Sweet, Nimgaonkar, Devlin, Jeste (CR13) 2003; 8 Schjeide, Schnack, Lambert, Lill, Kirchheiner, Tumani (CR72) 2011; 68 Carrasquillo, Belbin, Hunter, Ma, Bisceglio, Zou (CR5) 2010; 67 Bacanu, Devlin, Chowdari, DeKosky, Nimgaonkar, Sweet (CR20) 2005; 13 Sweet, Bennett, Graff-Radford, Mayeux (CR21) 2010; 133 Ganguli, Dodge, Chen, Belle, DeKosky (CR30) 2000; 54 Rule, de Andrade, Matsumoto, Mosley, Kardia, Turner (CR57) 2011; 50 Corneveaux, Myers, Allen, Pruzin, Ramirez, Engel (CR3) 2010; 19 Hollingworth, Hamshere, Moskvina, Dowzell, Moore, Foy (CR35) 2006; 54 Willer, Li, Abecasis (CR43) 2010; 26 Price, Patterson, Plenge, Weinblatt, Shadick, Reich (CR40) 2006; 38 Manolio, Collins, Cox, Goldstein, Hindorff, Hunter (CR11) 2009; 461 Hollingworth, Harold, Jones, Owen, Williams (CR1) 2011; 26 Lopez, Wisniewski, Becker, Boller, DeKosky (CR17) 1999; 56 Beveridge, Tooney, Carroll, Gardiner, Bowden, Scott (CR55) 2008; 17 Lee, Cheng, Graff-Radford, Foroud, Mayeux (CR27) 2008; 65 Lambert, Heath, Even, Campion, Sleegers, Hiltunen (CR45) 2009; 41 Lee, Luca, Klei, Devlin, Roeder (CR42) 2010; 34 Stefansson, Ophoff, Steinberg, Andreassen, Cichon, Rujescu (CR46) 2009; 460 Yao, Reddy, van Kammen (CR60) 1998; 80 Purcell, Neale, Todd-Brown, Thomas, Ferreira, Bender (CR41) 2007; 81 Vitart, Rudan, Hayward, Gray, Floyd, Palmer (CR58) 2008; 40 Lichtenstein, Yip, Bjork, Pawitan, Cannon, Sullivan (CR66) 2009; 373 Bowman, Shannon, Frei, Kaye, Quinn (CR59) 2010; 19 Naj, Jun, Beecham, Wang, Vardarajan, Buros (CR10) 2011; 43 Mirra, Heyman, McKeel, Sumi, Crain, Brownlee (CR26) 1991; 41 Cichon, Muhleisen, Degenhardt, Mattheisen, Miro, Strohmaier (CR50) 2011; 88 Martins-de-Souza, Gattaz, Schmitt, Rewerts, Marangoni, Novello (CR56) 2009; 116 Braunewell, Klein-Szanto (CR53) 2009; 335 Shin, Carter, Masterman, Fairbanks, Cummings (CR15) 2005; 13 McKhann, Drachman, Folstein, Katzman, Price, Stadlan (CR25) 1984; 34 Folstein, Folstein, McHugh (CR38) 1975; 12 Tariot, Mack, Patterson, Edland, Weiner, Fillenbaum (CR33) 1995; 152 Reddy, Keshavan, Yao (CR61) 2003; 62 Biffi, Anderson, Desikan, Sabuncu, Cortellini, Schmansky (CR7) 2010; 67 Wilkosz, Kodavali, Weamer, Miyahara, Lopez, Nimgaonkar (CR34) 2007; 144B Weamer, Emanuel, Varon, Miyahara, Wilkosz, Lopez (CR28) 2009; 21 Purcell, Wray, Stone, Visscher, O’Donovan, Sullivan (CR67) 2009; 460 Sweet, Nimgaonkar, Devlin, Lopez, DeKosky (CR19) 2002; 58 CR65 O’Donovan, Craddock, Owen (CR12) 2009; 126 Jun, Naj, Beecham, Wang, Buros, Gallins (CR6) 2010; 67 Reisberg, Ferris, de Leon, Crook (CR36) 1982; 139 Lettre, Rioux (CR68) 2008; 17 Demichele-Sweet, Lopez, Sweet (CR64) 2011; 2011 Demichele-Sweet, Kleia, Devlin, Ferrellb, Weamera, Emanuela (CR24) 2011; 32 Zhang, Yu, Zhu, Zhang, Wu, Miao (CR4) 2010; 1348 D Martins-de-Souza (BFmp2011125_CR56) 2009; 116 P Hollingworth (BFmp2011125_CR9) 2011; 43 RA Sweet (BFmp2011125_CR13) 2003; 8 Q Zhang (BFmp2011125_CR4) 2010; 1348 PA Wilkosz (BFmp2011125_CR16) 2010; 22 CJ Willer (BFmp2011125_CR43) 2010; 26 OL Lopez (BFmp2011125_CR29) 2003; 37 BFmp2011125_CR71 JK Yao (BFmp2011125_CR60) 1998; 80 S Purcell (BFmp2011125_CR41) 2007; 81 CH Lee (BFmp2011125_CR63) 2010; 17 JL Cummings (BFmp2011125_CR32) 1997; 48 JH Lee (BFmp2011125_CR27) 2008; 65 NJ Beveridge (BFmp2011125_CR55) 2008; 17 TA Manolio (BFmp2011125_CR11) 2009; 461 MC Whitlock (BFmp2011125_CR52) 2005; 18 SA Ropacki (BFmp2011125_CR14) 2005; 162 OL Lopez (BFmp2011125_CR17) 1999; 56 FJ McMahon (BFmp2011125_CR49) 2010; 42 EA Weamer (BFmp2011125_CR28) 2009; 21 MA Ferreira (BFmp2011125_CR48) 2008; 40 P Hollingworth (BFmp2011125_CR35) 2006; 54 BFmp2011125_CR65 IS Shin (BFmp2011125_CR15) 2005; 13 M Kam (BFmp2011125_CR62) 2006; 51 SA Bacanu (BFmp2011125_CR20) 2005; 13 SM Purcell (BFmp2011125_CR67) 2009; 460 JC Lambert (BFmp2011125_CR45) 2009; 41 MF Folstein (BFmp2011125_CR38) 1975; 12 B Reisberg (BFmp2011125_CR36) 1982; 139 MM Carrasquillo (BFmp2011125_CR5) 2010; 67 G McKhann (BFmp2011125_CR25) 1984; 34 V Moskvina (BFmp2011125_CR70) 2005; 69 AB Lee (BFmp2011125_CR42) 2010; 34 JJ Corneveaux (BFmp2011125_CR3) 2010; 19 PA Wilkosz (BFmp2011125_CR34) 2007; 144B S Seshadri (BFmp2011125_CR8) 2010; 303 M Ganguli (BFmp2011125_CR30) 2000; 54 J Shi (BFmp2011125_CR51) 2009; 460 R Reddy (BFmp2011125_CR61) 2003; 62 A Biffi (BFmp2011125_CR7) 2010; 67 B Devlin (BFmp2011125_CR44) 1999; 55 GL Bowman (BFmp2011125_CR59) 2010; 19 G Jun (BFmp2011125_CR6) 2010; 67 JL Cummings (BFmp2011125_CR31) 1994; 44 L Berg (BFmp2011125_CR37) 1988; 24 BM Schjeide (BFmp2011125_CR72) 2011; 68 D Harold (BFmp2011125_CR2) 2009; 41 S Cichon (BFmp2011125_CR50) 2011; 88 MC O’Donovan (BFmp2011125_CR12) 2009; 126 MA DeMichele-Sweet (BFmp2011125_CR22) 2010; 19 RA Sweet (BFmp2011125_CR19) 2002; 58 SS Mirra (BFmp2011125_CR26) 1991; 41 KH Braunewell (BFmp2011125_CR53) 2009; 335 MC O’Donovan (BFmp2011125_CR47) 2008; 40 AD Rule (BFmp2011125_CR57) 2011; 50 P Hollingworth (BFmp2011125_CR1) 2011; 26 N Craddock (BFmp2011125_CR69) 2009; 35 AL Price (BFmp2011125_CR40) 2006; 38 RA Sweet (BFmp2011125_CR21) 2010; 133 MA Demichele-Sweet (BFmp2011125_CR24) 2011; 32 MA Demichele-Sweet (BFmp2011125_CR64) 2011; 2011 PN Tariot (BFmp2011125_CR33) 1995; 152 EM Wijsman (BFmp2011125_CR23) 2011; 7 BFmp2011125_CR39 G Lettre (BFmp2011125_CR68) 2008; 17 P Lichtenstein (BFmp2011125_CR66) 2009; 373 P Hollingworth (BFmp2011125_CR18) 2007; 144B V Vitart (BFmp2011125_CR58) 2008; 40 H Stefansson (BFmp2011125_CR46) 2009; 460 JM Lee (BFmp2011125_CR54) 2008; 54 AC Naj (BFmp2011125_CR10) 2011; 43 |
References_xml | – volume: 8 start-page: 383 year: 2003 end-page: 392 article-title: Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype publication-title: Mol Psychiatry contributor: fullname: Jeste, DV – volume: 34 start-page: 51 year: 2010 end-page: 59 article-title: Discovering genetic ancestry using spectral graph theory publication-title: Genet Epidemiol contributor: fullname: Roeder, K – volume: 65 start-page: 1518 year: 2008 end-page: 1526 article-title: Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci publication-title: Arch Neurol contributor: fullname: Mayeux, R – volume: 42 start-page: 128 year: 2010 end-page: 131 article-title: Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1 publication-title: Nat Genet contributor: fullname: Detera-Wadleigh, SD – volume: 460 start-page: 748 year: 2009 end-page: 752 article-title: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder publication-title: Nature contributor: fullname: Sullivan, PF – volume: 7 start-page: e1001308 year: 2011 article-title: Genome wide association of familial late onset Alzheimer's disease replicates BIN1 and CLU, and nominates CUGBP2 in interaction with APOE publication-title: PLoS Genet contributor: fullname: Cheng, R – volume: 41 start-page: 1088 year: 2009 end-page: 1093 article-title: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease publication-title: Nat Genet contributor: fullname: Hamshere, ML – volume: 116 start-page: 275 year: 2009 end-page: 289 article-title: Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis publication-title: J Neural Transm contributor: fullname: Novello, JC – volume: 2011 start-page: 926597 year: 2011 article-title: Psychosis in Alzheimer's disease in the national Alzheimer's disease coordinating center uniform data set: clinical correlates and association with apolipoprotein e publication-title: Int J Alzheimers Dis contributor: fullname: Sweet, RA – volume: 13 start-page: 469 year: 2005 end-page: 474 article-title: Neuropsychiatric symptoms and quality of life in Alzheimer disease publication-title: Am J Geriatr Psychiatry contributor: fullname: Cummings, JL – volume: 13 start-page: 624 year: 2005 end-page: 627 article-title: Heritability of psychosis in Alzheimer disease publication-title: Am J Geriatr Psychiatry contributor: fullname: Sweet, RA – volume: 44 start-page: 2308 year: 1994 end-page: 2314 article-title: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia publication-title: Neurology contributor: fullname: Gornbein, J – volume: 40 start-page: 1056 year: 2008 end-page: 1058 article-title: Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder publication-title: Nat Genet contributor: fullname: Jones, L – volume: 126 start-page: 3 year: 2009 end-page: 12 article-title: Genetics of psychosis; insights from views across the genome publication-title: Hum Genet contributor: fullname: Owen, MJ – volume: 54 start-page: 1617 year: 2008 end-page: 1623 article-title: The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients publication-title: Clin Chem contributor: fullname: Olander, J – volume: 40 start-page: 437 year: 2008 end-page: 442 article-title: SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout publication-title: Nat Genet contributor: fullname: Palmer, CN – volume: 17 start-page: R116 year: 2008 end-page: R121 article-title: Autoimmune diseases: insights from genome-wide association studies publication-title: Hum Mol Genet contributor: fullname: Rioux, JD – volume: 152 start-page: 1349 year: 1995 end-page: 1357 article-title: The behavior rating scale for dementia of the consortium to establish a registry for Alzheimer's disease. The behavioral pathology committee of the consortium to establish a registry for Alzheimer's disease publication-title: Am J Psychiatry contributor: fullname: Fillenbaum, G – volume: 54 start-page: 1348 year: 2006 end-page: 1354 article-title: Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease publication-title: J Am Geriatr Soc contributor: fullname: Foy, C – volume: 139 start-page: 1136 year: 1982 end-page: 1139 article-title: The Global Deterioration Scale for assessment of primary degenerative dementia publication-title: Am J Psychiatry contributor: fullname: Crook, T – volume: 50 start-page: 871 year: 2011 end-page: 878 article-title: Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families publication-title: Rheumatology (Oxford) contributor: fullname: Turner, ST – volume: 21 start-page: 78 year: 2009 end-page: 85 article-title: The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis publication-title: Int Psychogeriatr contributor: fullname: Lopez, OL – volume: 67 start-page: 961 year: 2010 end-page: 964 article-title: Replication of CLU, CR1, and PICALM associations with Alzheimer disease publication-title: Arch Neurol contributor: fullname: Zou, F – volume: 303 start-page: 1832 year: 2010 end-page: 1840 article-title: Genome-wide analysis of genetic loci associated with Alzheimer disease publication-title: JAMA contributor: fullname: Boada, M – volume: 69 start-page: 566 year: 2005 end-page: 576 article-title: Design of case-controls studies with unscreened controls publication-title: Ann Hum Genet contributor: fullname: Craddock, N – volume: 26 start-page: 793 year: 2011 end-page: 802 article-title: Alzheimer's disease genetics: current knowledge and future challenges publication-title: Int J Geriatr Psychiatry contributor: fullname: Williams, J – volume: 162 start-page: 2022 year: 2005 end-page: 2030 article-title: Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003 publication-title: Am J Psychiatry contributor: fullname: Jeste, DV – year: 2010 article-title: Association of CLU and PICALM variants with Alzheimer's disease publication-title: Neurobiol Aging contributor: fullname: Lopez, OL – volume: 22 start-page: 281 year: 2010 end-page: 290 article-title: Trajectories of cognitive decline in Alzheimer's disease publication-title: Int Psychogeriatr contributor: fullname: Dekosky, ST – volume: 19 start-page: 761 year: 2010 end-page: 780 article-title: Genetics of psychosis in Alzheimer's disease: a review publication-title: J Alzheimers Dis contributor: fullname: Sweet, RA – volume: 32 start-page: 555.e9 year: 2011 end-page: 555.e11 article-title: No association of psychosis in Alzheimer disease with neurodegenerative pathway genes publication-title: Neurobiol Aging contributor: fullname: Emanuela, JE – volume: 17 start-page: 2 year: 2010 article-title: Genetic copy number variants in sib pairs both affected with schizophrenia publication-title: J Biomed Sci contributor: fullname: Hwu, HG – volume: 19 start-page: 1331 year: 2010 end-page: 1336 article-title: Uric acid as a CNS antioxidant publication-title: J Alzheimers Dis contributor: fullname: Quinn, JF – volume: 35 start-page: 482 year: 2009 end-page: 490 article-title: Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses publication-title: Schizophr Bull contributor: fullname: Owen, MJ – year: 2011 article-title: TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease publication-title: Neurobiol Aging contributor: fullname: Kamboh, MI – volume: 26 start-page: 2190 year: 2010 end-page: 2191 article-title: METAL: fast and efficient meta-analysis of genomewide association scans publication-title: Bioinformatics contributor: fullname: Abecasis, GR – volume: 56 start-page: 1266 year: 1999 end-page: 1272 article-title: Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease publication-title: Arch Neurol contributor: fullname: DeKosky, ST – volume: 54 start-page: 1109 year: 2000 end-page: 1116 article-title: Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project publication-title: Neurology contributor: fullname: DeKosky, ST – volume: 43 start-page: 429 year: 2011 end-page: 435 article-title: Common variants in ABCA7, MS4A6A MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease publication-title: Nat Genet contributor: fullname: Carrasquillo, MM – volume: 144B start-page: 841 year: 2007 end-page: 848 article-title: Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis publication-title: Am J Med Genet B Neuropsychiatr Genet contributor: fullname: Powell, J – volume: 41 start-page: 479 year: 1991 end-page: 486 article-title: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease publication-title: Neurology contributor: fullname: Brownlee, LM – volume: 51 start-page: 1567 year: 2006 end-page: 1570 article-title: Peutz-Jeghers syndrome diagnosed in a schizophrenic patient with a large deletion in the STK11 gene publication-title: Dig Dis Sci contributor: fullname: Dingell, JD – volume: 12 start-page: 189 year: 1975 end-page: 198 article-title: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res contributor: fullname: McHugh, PR – volume: 58 start-page: 907 year: 2002 end-page: 911 article-title: Increased familial risk of the psychotic phenotype of Alzheimer disease publication-title: Neurology contributor: fullname: DeKosky, ST – volume: 19 start-page: 3295 year: 2010 end-page: 3301 article-title: Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals publication-title: Hum Mol Genet contributor: fullname: Engel, A – volume: 1348 start-page: 216 year: 2010 end-page: 221 article-title: Complement receptor 1 polymorphisms and risk of late onset Alzheimer's disease publication-title: Brain Res contributor: fullname: Miao, D – volume: 144B start-page: 1054 year: 2007 end-page: 1062 article-title: Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism publication-title: Am J Med Genet B Neuropsychiatr Genet contributor: fullname: Nimgaonkar, VL – volume: 18 start-page: 1368 year: 2005 end-page: 1373 article-title: Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach publication-title: J Evol Biol contributor: fullname: Whitlock, MC – volume: 17 start-page: 1156 year: 2008 end-page: 1168 article-title: Dysregulation of miRNA 181b in the temporal cortex in schizophrenia publication-title: Hum Mol Genet contributor: fullname: Scott, RJ – volume: 460 start-page: 744 year: 2009 end-page: 747 article-title: Common variants conferring risk of schizophrenia publication-title: Nature contributor: fullname: Rujescu, D – volume: 81 start-page: 559 year: 2007 end-page: 575 article-title: PLINK: a tool set for whole-genome association and population-based linkage analyses publication-title: Am J Hum Genet contributor: fullname: Bender, D – volume: 461 start-page: 747 year: 2009 end-page: 753 article-title: Finding the missing heritability of complex diseases publication-title: Nature contributor: fullname: Hunter, DJ – volume: 43 start-page: 436 year: 2011 end-page: 441 article-title: Common variants at MS4A4 MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease publication-title: Nat Genet contributor: fullname: Buros, J – volume: 133 start-page: 1155 year: 2010 end-page: 1162 article-title: Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study publication-title: Brain contributor: fullname: Mayeux, R – volume: 335 start-page: 301 year: 2009 end-page: 316 article-title: Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+ -sensor proteins publication-title: Cell Tissue Res contributor: fullname: Klein-Szanto, AJ – volume: 80 start-page: 29 year: 1998 end-page: 39 article-title: Reduced level of plasma antioxidant uric acid in schizophrenia publication-title: Psychiatry Res contributor: fullname: van Kammen, DP – volume: 67 start-page: 1473 year: 2010 end-page: 1484 article-title: Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes publication-title: Arch Neurol contributor: fullname: Gallins, PJ – volume: 38 start-page: 904 year: 2006 end-page: 909 article-title: Principal components analysis corrects for stratification in genome-wide association studies publication-title: Nat Genet contributor: fullname: Reich, D – volume: 67 start-page: 677 year: 2010 end-page: 685 article-title: Genetic variation and neuroimaging measures in Alzheimer disease publication-title: Arch Neurol contributor: fullname: Schmansky, N – volume: 40 start-page: 1053 year: 2008 end-page: 1055 article-title: Identification of loci associated with schizophrenia by genome-wide association and follow-up publication-title: Nat Genet contributor: fullname: Moskvina, V – volume: 62 start-page: 205 year: 2003 end-page: 212 article-title: Reduced plasma antioxidants in first-episode patients with schizophrenia publication-title: Schizophr Res contributor: fullname: Yao, JK – volume: 460 start-page: 753 year: 2009 end-page: 757 article-title: Common variants on chromosome 6p22.1 are associated with schizophrenia publication-title: Nature contributor: fullname: Pe'er, I – volume: 24 start-page: 637 year: 1988 end-page: 639 article-title: Clinical Dementia Rating (CDR) publication-title: Psychopharmacol Bull contributor: fullname: Berg, L – volume: 373 start-page: 234 year: 2009 end-page: 239 article-title: Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study publication-title: Lancet contributor: fullname: Sullivan, PF – volume: 34 start-page: 939 year: 1984 end-page: 944 article-title: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease publication-title: Neurology contributor: fullname: Stadlan, EM – volume: 37 start-page: 155 year: 2003 end-page: 163 article-title: Neuropathology of Alzheimer's disease and mild cognitive impairment] publication-title: Rev Neurol contributor: fullname: DeKosky, ST – volume: 88 start-page: 372 year: 2011 end-page: 381 article-title: Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder publication-title: Am J Hum Genet contributor: fullname: Strohmaier, J – year: 2011 article-title: Genome-wide association analysis of age-at-onset in Alzheimer's disease publication-title: Mol Psychiatry contributor: fullname: Pankratz, VS – volume: 55 start-page: 997 year: 1999 end-page: 1004 article-title: Genomic control for association studies publication-title: Biometrics contributor: fullname: Roeder, K – volume: 41 start-page: 1094 year: 2009 end-page: 1099 article-title: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease publication-title: Nat Genet contributor: fullname: Hiltunen, M – volume: 68 start-page: 207 year: 2011 end-page: 213 article-title: The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels publication-title: Arch Gen Psychiatry contributor: fullname: Tumani, H – volume: 48 start-page: S10 year: 1997 end-page: S16 article-title: The Neuropsychiatric Inventory: assessing psychopathology in dementia patients publication-title: Neurology contributor: fullname: Cummings, JL – volume: 17 start-page: 2 year: 2010 ident: CR63 article-title: Genetic copy number variants in sib pairs both affected with schizophrenia publication-title: J Biomed Sci doi: 10.1186/1423-0127-17-2 contributor: fullname: Hwu – volume: 68 start-page: 207 year: 2011 end-page: 213 ident: CR72 article-title: The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2010.196 contributor: fullname: Tumani – volume: 32 start-page: 555.e9 year: 2011 end-page: 555.e11 ident: CR24 article-title: No association of psychosis in Alzheimer disease with neurodegenerative pathway genes publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2010.10.003 contributor: fullname: Emanuela – volume: 144B start-page: 1054 year: 2007 end-page: 1062 ident: CR34 article-title: Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30549 contributor: fullname: Nimgaonkar – ident: CR39 – volume: 40 start-page: 1053 year: 2008 end-page: 1055 ident: CR47 article-title: Identification of loci associated with schizophrenia by genome-wide association and follow-up publication-title: Nat Genet doi: 10.1038/ng.201 contributor: fullname: Moskvina – volume: 116 start-page: 275 year: 2009 end-page: 289 ident: CR56 article-title: Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis publication-title: J Neural Transm doi: 10.1007/s00702-008-0156-y contributor: fullname: Novello – volume: 460 start-page: 748 year: 2009 end-page: 752 ident: CR67 article-title: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder publication-title: Nature contributor: fullname: Sullivan – volume: 41 start-page: 1088 year: 2009 end-page: 1093 ident: CR2 article-title: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease publication-title: Nat Genet doi: 10.1038/ng.440 contributor: fullname: Hamshere – volume: 22 start-page: 281 year: 2010 end-page: 290 ident: CR16 article-title: Trajectories of cognitive decline in Alzheimer’s disease publication-title: Int Psychogeriatr doi: 10.1017/S1041610209991001 contributor: fullname: Dekosky – volume: 40 start-page: 1056 year: 2008 end-page: 1058 ident: CR48 article-title: Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder publication-title: Nat Genet doi: 10.1038/ng.209 contributor: fullname: Jones – volume: 13 start-page: 469 year: 2005 end-page: 474 ident: CR15 article-title: Neuropsychiatric symptoms and quality of life in Alzheimer disease publication-title: Am J Geriatr Psychiatry doi: 10.1097/00019442-200506000-00005 contributor: fullname: Cummings – volume: 80 start-page: 29 year: 1998 end-page: 39 ident: CR60 article-title: Reduced level of plasma antioxidant uric acid in schizophrenia publication-title: Psychiatry Res doi: 10.1016/S0165-1781(98)00051-1 contributor: fullname: van Kammen – volume: 144B start-page: 841 year: 2007 end-page: 848 ident: CR18 article-title: Increased familial risk and genomewide significant linkage for Alzheimer’s disease with psychosis publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30515 contributor: fullname: Powell – volume: 19 start-page: 761 year: 2010 end-page: 780 ident: CR22 article-title: Genetics of psychosis in Alzheimer’s disease: a review publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-1274 contributor: fullname: Sweet – volume: 38 start-page: 904 year: 2006 end-page: 909 ident: CR40 article-title: Principal components analysis corrects for stratification in genome-wide association studies publication-title: Nat Genet doi: 10.1038/ng1847 contributor: fullname: Reich – volume: 55 start-page: 997 year: 1999 end-page: 1004 ident: CR44 article-title: Genomic control for association studies publication-title: Biometrics doi: 10.1111/j.0006-341X.1999.00997.x contributor: fullname: Roeder – volume: 17 start-page: R116 issue: R2 year: 2008 end-page: R121 ident: CR68 article-title: Autoimmune diseases: insights from genome-wide association studies publication-title: Hum Mol Genet doi: 10.1093/hmg/ddn246 contributor: fullname: Rioux – volume: 133 start-page: 1155 issue: Part 4 year: 2010 end-page: 1162 ident: CR21 article-title: Assessment and familial aggregation of psychosis in Alzheimer’s disease from the National Institute on Aging Late Onset Alzheimer’s Disease Family Study publication-title: Brain doi: 10.1093/brain/awq001 contributor: fullname: Mayeux – volume: 43 start-page: 429 year: 2011 end-page: 435 ident: CR9 article-title: Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease publication-title: Nat Genet doi: 10.1038/ng.803 contributor: fullname: Carrasquillo – volume: 13 start-page: 624 year: 2005 end-page: 627 ident: CR20 article-title: Heritability of psychosis in Alzheimer disease publication-title: Am J Geriatr Psychiatry doi: 10.1097/00019442-200507000-00011 contributor: fullname: Sweet – volume: 24 start-page: 637 year: 1988 end-page: 639 ident: CR37 article-title: Clinical Dementia Rating (CDR) publication-title: Psychopharmacol Bull contributor: fullname: Berg – volume: 21 start-page: 78 year: 2009 end-page: 85 ident: CR28 article-title: The relationship of excess cognitive impairment in MCI and early Alzheimer’s disease to the subsequent emergence of psychosis publication-title: Int Psychogeriatr doi: 10.1017/S1041610208007734 contributor: fullname: Lopez – volume: 81 start-page: 559 year: 2007 end-page: 575 ident: CR41 article-title: PLINK: a tool set for whole-genome association and population-based linkage analyses publication-title: Am J Hum Genet doi: 10.1086/519795 contributor: fullname: Bender – ident: CR71 – volume: 12 start-page: 189 year: 1975 end-page: 198 ident: CR38 article-title: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res doi: 10.1016/0022-3956(75)90026-6 contributor: fullname: McHugh – volume: 373 start-page: 234 year: 2009 end-page: 239 ident: CR66 article-title: Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study publication-title: Lancet doi: 10.1016/S0140-6736(09)60072-6 contributor: fullname: Sullivan – volume: 67 start-page: 1473 year: 2010 end-page: 1484 ident: CR6 article-title: Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes publication-title: Arch Neurol doi: 10.1001/archneurol.2010.201 contributor: fullname: Gallins – volume: 54 start-page: 1348 year: 2006 end-page: 1354 ident: CR35 article-title: Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer’s disease publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2006.00854.x contributor: fullname: Foy – volume: 17 start-page: 1156 year: 2008 end-page: 1168 ident: CR55 article-title: Dysregulation of miRNA 181b in the temporal cortex in schizophrenia publication-title: Hum Mol Genet doi: 10.1093/hmg/ddn005 contributor: fullname: Scott – volume: 162 start-page: 2022 year: 2005 end-page: 2030 ident: CR14 article-title: Epidemiology of and risk factors for psychosis of Alzheimer’s disease: a review of 55 studies published from 1990 to 2003 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.162.11.2022 contributor: fullname: Jeste – volume: 18 start-page: 1368 year: 2005 end-page: 1373 ident: CR52 article-title: Combining probability from independent tests: the weighted Z-method is superior to Fisher’s approach publication-title: J Evol Biol doi: 10.1111/j.1420-9101.2005.00917.x contributor: fullname: Whitlock – volume: 51 start-page: 1567 year: 2006 end-page: 1570 ident: CR62 article-title: Peutz-Jeghers syndrome diagnosed in a schizophrenic patient with a large deletion in the STK11 gene publication-title: Dig Dis Sci doi: 10.1007/s10620-006-9102-8 contributor: fullname: Dingell – volume: 88 start-page: 372 year: 2011 end-page: 381 ident: CR50 article-title: Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2011.01.017 contributor: fullname: Strohmaier – volume: 50 start-page: 871 year: 2011 end-page: 878 ident: CR57 article-title: Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keq425 contributor: fullname: Turner – volume: 67 start-page: 677 year: 2010 end-page: 685 ident: CR7 article-title: Genetic variation and neuroimaging measures in Alzheimer disease publication-title: Arch Neurol doi: 10.1001/archneurol.2010.108 contributor: fullname: Schmansky – volume: 34 start-page: 51 year: 2010 end-page: 59 ident: CR42 article-title: Discovering genetic ancestry using spectral graph theory publication-title: Genet Epidemiol doi: 10.1002/gepi.20541 contributor: fullname: Roeder – volume: 1348 start-page: 216 year: 2010 end-page: 221 ident: CR4 article-title: Complement receptor 1 polymorphisms and risk of late onset Alzheimer’s disease publication-title: Brain Res doi: 10.1016/j.brainres.2010.06.018 contributor: fullname: Miao – volume: 56 start-page: 1266 year: 1999 end-page: 1272 ident: CR17 article-title: Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease publication-title: Arch Neurol doi: 10.1001/archneur.56.10.1266 contributor: fullname: DeKosky – volume: 460 start-page: 744 year: 2009 end-page: 747 ident: CR46 article-title: Common variants conferring risk of schizophrenia publication-title: Nature contributor: fullname: Rujescu – volume: 7 start-page: e1001308 year: 2011 ident: CR23 article-title: Genome wide association of familial late onset Alzheimer’s disease replicates BIN1 and CLU, and nominates CUGBP2 in interaction with APOE publication-title: PLoS Genet doi: 10.1371/journal.pgen.1001308 contributor: fullname: Cheng – volume: 152 start-page: 1349 year: 1995 end-page: 1357 ident: CR33 article-title: The behavior rating scale for dementia of the consortium to establish a registry for Alzheimer’s disease. The behavioral pathology committee of the consortium to establish a registry for Alzheimer’s disease publication-title: Am J Psychiatry doi: 10.1176/ajp.152.9.1349 contributor: fullname: Fillenbaum – volume: 19 start-page: 1331 year: 2010 end-page: 1336 ident: CR59 article-title: Uric acid as a CNS antioxidant publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-1330 contributor: fullname: Quinn – volume: 35 start-page: 482 year: 2009 end-page: 490 ident: CR69 article-title: Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or “schizoaffective”) psychoses publication-title: Schizophr Bull doi: 10.1093/schbul/sbp020 contributor: fullname: Owen – volume: 2011 start-page: 926597 year: 2011 ident: CR64 article-title: Psychosis in Alzheimer’s disease in the national Alzheimer’s disease coordinating center uniform data set: clinical correlates and association with apolipoprotein e publication-title: Int J Alzheimers Dis contributor: fullname: Sweet – volume: 335 start-page: 301 year: 2009 end-page: 316 ident: CR53 article-title: Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+ -sensor proteins publication-title: Cell Tissue Res doi: 10.1007/s00441-008-0716-3 contributor: fullname: Klein-Szanto – volume: 303 start-page: 1832 year: 2010 end-page: 1840 ident: CR8 article-title: Genome-wide analysis of genetic loci associated with Alzheimer disease publication-title: JAMA doi: 10.1001/jama.2010.574 contributor: fullname: Boada – volume: 37 start-page: 155 year: 2003 end-page: 163 ident: CR29 article-title: Neuropathology of Alzheimer’s disease and mild cognitive impairment] publication-title: Rev Neurol contributor: fullname: DeKosky – volume: 58 start-page: 907 year: 2002 end-page: 911 ident: CR19 article-title: Increased familial risk of the psychotic phenotype of Alzheimer disease publication-title: Neurology doi: 10.1212/WNL.58.6.907 contributor: fullname: DeKosky – volume: 69 start-page: 566 issue: Part 5 year: 2005 end-page: 576 ident: CR70 article-title: Design of case-controls studies with unscreened controls publication-title: Ann Hum Genet doi: 10.1111/j.1529-8817.2005.00175.x contributor: fullname: Craddock – volume: 67 start-page: 961 year: 2010 end-page: 964 ident: CR5 article-title: Replication of CLU, CR1, and PICALM associations with Alzheimer disease publication-title: Arch Neurol doi: 10.1001/archneurol.2010.147 contributor: fullname: Zou – volume: 40 start-page: 437 year: 2008 end-page: 442 ident: CR58 article-title: SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout publication-title: Nat Genet doi: 10.1038/ng.106 contributor: fullname: Palmer – volume: 62 start-page: 205 year: 2003 end-page: 212 ident: CR61 article-title: Reduced plasma antioxidants in first-episode patients with schizophrenia publication-title: Schizophr Res doi: 10.1016/S0920-9964(02)00407-3 contributor: fullname: Yao – volume: 43 start-page: 436 year: 2011 end-page: 441 ident: CR10 article-title: Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease publication-title: Nat Genet doi: 10.1038/ng.801 contributor: fullname: Buros – volume: 8 start-page: 383 year: 2003 end-page: 392 ident: CR13 article-title: Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001262 contributor: fullname: Jeste – volume: 54 start-page: 1109 year: 2000 end-page: 1116 ident: CR30 article-title: Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project publication-title: Neurology doi: 10.1212/WNL.54.5.1109 contributor: fullname: DeKosky – volume: 26 start-page: 2190 year: 2010 end-page: 2191 ident: CR43 article-title: METAL: fast and efficient meta-analysis of genomewide association scans publication-title: Bioinformatics doi: 10.1093/bioinformatics/btq340 contributor: fullname: Abecasis – volume: 34 start-page: 939 year: 1984 end-page: 944 ident: CR25 article-title: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease publication-title: Neurology doi: 10.1212/WNL.34.7.939 contributor: fullname: Stadlan – volume: 19 start-page: 3295 year: 2010 end-page: 3301 ident: CR3 article-title: Association of CR1, CLU and PICALM with Alzheimer’s disease in a cohort of clinically characterized and neuropathologically verified individuals publication-title: Hum Mol Genet doi: 10.1093/hmg/ddq221 contributor: fullname: Engel – volume: 65 start-page: 1518 year: 2008 end-page: 1526 ident: CR27 article-title: Analyses of the National Institute on Aging Late-Onset Alzheimer’s Disease Family Study: implication of additional loci publication-title: Arch Neurol doi: 10.1001/archneur.65.11.1518 contributor: fullname: Mayeux – ident: CR65 – volume: 54 start-page: 1617 year: 2008 end-page: 1623 ident: CR54 article-title: The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients publication-title: Clin Chem doi: 10.1373/clinchem.2008.104497 contributor: fullname: Olander – volume: 139 start-page: 1136 year: 1982 end-page: 1139 ident: CR36 article-title: The Global Deterioration Scale for assessment of primary degenerative dementia publication-title: Am J Psychiatry doi: 10.1176/ajp.139.9.1136 contributor: fullname: Crook – volume: 44 start-page: 2308 year: 1994 end-page: 2314 ident: CR31 article-title: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia publication-title: Neurology doi: 10.1212/WNL.44.12.2308 contributor: fullname: Gornbein – volume: 41 start-page: 479 year: 1991 end-page: 486 ident: CR26 article-title: The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease publication-title: Neurology doi: 10.1212/WNL.41.4.479 contributor: fullname: Brownlee – volume: 461 start-page: 747 year: 2009 end-page: 753 ident: CR11 article-title: Finding the missing heritability of complex diseases publication-title: Nature doi: 10.1038/nature08494 contributor: fullname: Hunter – volume: 48 start-page: S10 issue: 5 Suppl 6 year: 1997 end-page: S16 ident: CR32 article-title: The Neuropsychiatric Inventory: assessing psychopathology in dementia patients publication-title: Neurology doi: 10.1212/WNL.48.5_Suppl_6.10S contributor: fullname: Cummings – volume: 42 start-page: 128 year: 2010 end-page: 131 ident: CR49 article-title: Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1 publication-title: Nat Genet doi: 10.1038/ng.523 contributor: fullname: Detera-Wadleigh – volume: 26 start-page: 793 year: 2011 end-page: 802 ident: CR1 article-title: Alzheimer’s disease genetics: current knowledge and future challenges publication-title: Int J Geriatr Psychiatry doi: 10.1002/gps.2628 contributor: fullname: Williams – volume: 126 start-page: 3 year: 2009 end-page: 12 ident: CR12 article-title: Genetics of psychosis; insights from views across the genome publication-title: Hum Genet doi: 10.1007/s00439-009-0703-0 contributor: fullname: Owen – volume: 41 start-page: 1094 year: 2009 end-page: 1099 ident: CR45 article-title: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease publication-title: Nat Genet doi: 10.1038/ng.439 contributor: fullname: Hiltunen – volume: 460 start-page: 753 year: 2009 end-page: 757 ident: CR51 article-title: Common variants on chromosome 6p22.1 are associated with schizophrenia publication-title: Nature contributor: fullname: Pe’er – volume: 43 start-page: 436 year: 2011 ident: BFmp2011125_CR10 publication-title: Nat Genet doi: 10.1038/ng.801 contributor: fullname: AC Naj – volume: 67 start-page: 961 year: 2010 ident: BFmp2011125_CR5 publication-title: Arch Neurol doi: 10.1001/archneurol.2010.147 contributor: fullname: MM Carrasquillo – volume: 116 start-page: 275 year: 2009 ident: BFmp2011125_CR56 publication-title: J Neural Transm doi: 10.1007/s00702-008-0156-y contributor: fullname: D Martins-de-Souza – volume: 41 start-page: 1088 year: 2009 ident: BFmp2011125_CR2 publication-title: Nat Genet doi: 10.1038/ng.440 contributor: fullname: D Harold – volume: 133 start-page: 1155 issue: Part 4 year: 2010 ident: BFmp2011125_CR21 publication-title: Brain doi: 10.1093/brain/awq001 contributor: fullname: RA Sweet – volume: 126 start-page: 3 year: 2009 ident: BFmp2011125_CR12 publication-title: Hum Genet doi: 10.1007/s00439-009-0703-0 contributor: fullname: MC O’Donovan – volume: 144B start-page: 841 year: 2007 ident: BFmp2011125_CR18 publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30515 contributor: fullname: P Hollingworth – volume: 373 start-page: 234 year: 2009 ident: BFmp2011125_CR66 publication-title: Lancet doi: 10.1016/S0140-6736(09)60072-6 contributor: fullname: P Lichtenstein – volume: 34 start-page: 51 year: 2010 ident: BFmp2011125_CR42 publication-title: Genet Epidemiol doi: 10.1002/gepi.20541 contributor: fullname: AB Lee – ident: BFmp2011125_CR39 doi: 10.1038/mp.2011.135 – volume: 18 start-page: 1368 year: 2005 ident: BFmp2011125_CR52 publication-title: J Evol Biol doi: 10.1111/j.1420-9101.2005.00917.x contributor: fullname: MC Whitlock – volume: 58 start-page: 907 year: 2002 ident: BFmp2011125_CR19 publication-title: Neurology doi: 10.1212/WNL.58.6.907 contributor: fullname: RA Sweet – volume: 35 start-page: 482 year: 2009 ident: BFmp2011125_CR69 publication-title: Schizophr Bull doi: 10.1093/schbul/sbp020 contributor: fullname: N Craddock – volume: 41 start-page: 479 year: 1991 ident: BFmp2011125_CR26 publication-title: Neurology doi: 10.1212/WNL.41.4.479 contributor: fullname: SS Mirra – volume: 48 start-page: S10 issue: 5 Suppl 6 year: 1997 ident: BFmp2011125_CR32 publication-title: Neurology doi: 10.1212/WNL.48.5_Suppl_6.10S contributor: fullname: JL Cummings – volume: 8 start-page: 383 year: 2003 ident: BFmp2011125_CR13 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001262 contributor: fullname: RA Sweet – volume: 32 start-page: 555.e9 year: 2011 ident: BFmp2011125_CR24 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2010.10.003 contributor: fullname: MA Demichele-Sweet – volume: 38 start-page: 904 year: 2006 ident: BFmp2011125_CR40 publication-title: Nat Genet doi: 10.1038/ng1847 contributor: fullname: AL Price – volume: 460 start-page: 744 year: 2009 ident: BFmp2011125_CR46 publication-title: Nature doi: 10.1038/nature08186 contributor: fullname: H Stefansson – volume: 460 start-page: 748 year: 2009 ident: BFmp2011125_CR67 publication-title: Nature doi: 10.1038/nature08185 contributor: fullname: SM Purcell – volume: 68 start-page: 207 year: 2011 ident: BFmp2011125_CR72 publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2010.196 contributor: fullname: BM Schjeide – volume: 37 start-page: 155 year: 2003 ident: BFmp2011125_CR29 publication-title: Rev Neurol contributor: fullname: OL Lopez – volume: 81 start-page: 559 year: 2007 ident: BFmp2011125_CR41 publication-title: Am J Hum Genet doi: 10.1086/519795 contributor: fullname: S Purcell – volume: 42 start-page: 128 year: 2010 ident: BFmp2011125_CR49 publication-title: Nat Genet doi: 10.1038/ng.523 contributor: fullname: FJ McMahon – volume: 80 start-page: 29 year: 1998 ident: BFmp2011125_CR60 publication-title: Psychiatry Res doi: 10.1016/S0165-1781(98)00051-1 contributor: fullname: JK Yao – volume: 54 start-page: 1617 year: 2008 ident: BFmp2011125_CR54 publication-title: Clin Chem doi: 10.1373/clinchem.2008.104497 contributor: fullname: JM Lee – volume: 54 start-page: 1109 year: 2000 ident: BFmp2011125_CR30 publication-title: Neurology doi: 10.1212/WNL.54.5.1109 contributor: fullname: M Ganguli – volume: 62 start-page: 205 year: 2003 ident: BFmp2011125_CR61 publication-title: Schizophr Res doi: 10.1016/S0920-9964(02)00407-3 contributor: fullname: R Reddy – volume: 26 start-page: 793 year: 2011 ident: BFmp2011125_CR1 publication-title: Int J Geriatr Psychiatry doi: 10.1002/gps.2628 contributor: fullname: P Hollingworth – volume: 12 start-page: 189 year: 1975 ident: BFmp2011125_CR38 publication-title: J Psychiatr Res doi: 10.1016/0022-3956(75)90026-6 contributor: fullname: MF Folstein – volume: 88 start-page: 372 year: 2011 ident: BFmp2011125_CR50 publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2011.01.017 contributor: fullname: S Cichon – volume: 139 start-page: 1136 year: 1982 ident: BFmp2011125_CR36 publication-title: Am J Psychiatry doi: 10.1176/ajp.139.9.1136 contributor: fullname: B Reisberg – volume: 65 start-page: 1518 year: 2008 ident: BFmp2011125_CR27 publication-title: Arch Neurol doi: 10.1001/archneur.65.11.1518 contributor: fullname: JH Lee – volume: 69 start-page: 566 issue: Part 5 year: 2005 ident: BFmp2011125_CR70 publication-title: Ann Hum Genet doi: 10.1111/j.1529-8817.2005.00175.x contributor: fullname: V Moskvina – volume: 40 start-page: 437 year: 2008 ident: BFmp2011125_CR58 publication-title: Nat Genet doi: 10.1038/ng.106 contributor: fullname: V Vitart – volume: 460 start-page: 753 year: 2009 ident: BFmp2011125_CR51 publication-title: Nature doi: 10.1038/nature08192 contributor: fullname: J Shi – volume: 67 start-page: 1473 year: 2010 ident: BFmp2011125_CR6 publication-title: Arch Neurol doi: 10.1001/archneurol.2010.201 contributor: fullname: G Jun – volume: 152 start-page: 1349 year: 1995 ident: BFmp2011125_CR33 publication-title: Am J Psychiatry doi: 10.1176/ajp.152.9.1349 contributor: fullname: PN Tariot – volume: 144B start-page: 1054 year: 2007 ident: BFmp2011125_CR34 publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30549 contributor: fullname: PA Wilkosz – volume: 26 start-page: 2190 year: 2010 ident: BFmp2011125_CR43 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btq340 contributor: fullname: CJ Willer – volume: 13 start-page: 469 year: 2005 ident: BFmp2011125_CR15 publication-title: Am J Geriatr Psychiatry doi: 10.1097/00019442-200506000-00005 contributor: fullname: IS Shin – volume: 2011 start-page: 926597 year: 2011 ident: BFmp2011125_CR64 publication-title: Int J Alzheimers Dis contributor: fullname: MA Demichele-Sweet – volume: 51 start-page: 1567 year: 2006 ident: BFmp2011125_CR62 publication-title: Dig Dis Sci doi: 10.1007/s10620-006-9102-8 contributor: fullname: M Kam – volume: 7 start-page: e1001308 year: 2011 ident: BFmp2011125_CR23 publication-title: PLoS Genet doi: 10.1371/journal.pgen.1001308 contributor: fullname: EM Wijsman – volume: 41 start-page: 1094 year: 2009 ident: BFmp2011125_CR45 publication-title: Nat Genet doi: 10.1038/ng.439 contributor: fullname: JC Lambert – volume: 40 start-page: 1053 year: 2008 ident: BFmp2011125_CR47 publication-title: Nat Genet doi: 10.1038/ng.201 contributor: fullname: MC O’Donovan – volume: 19 start-page: 761 year: 2010 ident: BFmp2011125_CR22 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-1274 contributor: fullname: MA DeMichele-Sweet – volume: 22 start-page: 281 year: 2010 ident: BFmp2011125_CR16 publication-title: Int Psychogeriatr doi: 10.1017/S1041610209991001 contributor: fullname: PA Wilkosz – volume: 17 start-page: 1156 year: 2008 ident: BFmp2011125_CR55 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddn005 contributor: fullname: NJ Beveridge – volume: 55 start-page: 997 year: 1999 ident: BFmp2011125_CR44 publication-title: Biometrics doi: 10.1111/j.0006-341X.1999.00997.x contributor: fullname: B Devlin – volume: 40 start-page: 1056 year: 2008 ident: BFmp2011125_CR48 publication-title: Nat Genet doi: 10.1038/ng.209 contributor: fullname: MA Ferreira – volume: 34 start-page: 939 year: 1984 ident: BFmp2011125_CR25 publication-title: Neurology doi: 10.1212/WNL.34.7.939 contributor: fullname: G McKhann – volume: 44 start-page: 2308 year: 1994 ident: BFmp2011125_CR31 publication-title: Neurology doi: 10.1212/WNL.44.12.2308 contributor: fullname: JL Cummings – volume: 54 start-page: 1348 year: 2006 ident: BFmp2011125_CR35 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2006.00854.x contributor: fullname: P Hollingworth – volume: 43 start-page: 429 year: 2011 ident: BFmp2011125_CR9 publication-title: Nat Genet doi: 10.1038/ng.803 contributor: fullname: P Hollingworth – volume: 13 start-page: 624 year: 2005 ident: BFmp2011125_CR20 publication-title: Am J Geriatr Psychiatry doi: 10.1097/00019442-200507000-00011 contributor: fullname: SA Bacanu – volume: 56 start-page: 1266 year: 1999 ident: BFmp2011125_CR17 publication-title: Arch Neurol doi: 10.1001/archneur.56.10.1266 contributor: fullname: OL Lopez – volume: 50 start-page: 871 year: 2011 ident: BFmp2011125_CR57 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keq425 contributor: fullname: AD Rule – volume: 67 start-page: 677 year: 2010 ident: BFmp2011125_CR7 publication-title: Arch Neurol doi: 10.1001/archneurol.2010.108 contributor: fullname: A Biffi – volume: 17 start-page: R116 issue: R2 year: 2008 ident: BFmp2011125_CR68 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddn246 contributor: fullname: G Lettre – volume: 162 start-page: 2022 year: 2005 ident: BFmp2011125_CR14 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.162.11.2022 contributor: fullname: SA Ropacki – volume: 461 start-page: 747 year: 2009 ident: BFmp2011125_CR11 publication-title: Nature doi: 10.1038/nature08494 contributor: fullname: TA Manolio – volume: 17 start-page: 2 year: 2010 ident: BFmp2011125_CR63 publication-title: J Biomed Sci doi: 10.1186/1423-0127-17-2 contributor: fullname: CH Lee – ident: BFmp2011125_CR65 doi: 10.1016/j.neurobiolaging.2011.06.016 – volume: 19 start-page: 3295 year: 2010 ident: BFmp2011125_CR3 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddq221 contributor: fullname: JJ Corneveaux – volume: 24 start-page: 637 year: 1988 ident: BFmp2011125_CR37 publication-title: Psychopharmacol Bull contributor: fullname: L Berg – volume: 303 start-page: 1832 year: 2010 ident: BFmp2011125_CR8 publication-title: JAMA doi: 10.1001/jama.2010.574 contributor: fullname: S Seshadri – volume: 19 start-page: 1331 year: 2010 ident: BFmp2011125_CR59 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-1330 contributor: fullname: GL Bowman – ident: BFmp2011125_CR71 – volume: 1348 start-page: 216 year: 2010 ident: BFmp2011125_CR4 publication-title: Brain Res doi: 10.1016/j.brainres.2010.06.018 contributor: fullname: Q Zhang – volume: 335 start-page: 301 year: 2009 ident: BFmp2011125_CR53 publication-title: Cell Tissue Res doi: 10.1007/s00441-008-0716-3 contributor: fullname: KH Braunewell – volume: 21 start-page: 78 year: 2009 ident: BFmp2011125_CR28 publication-title: Int Psychogeriatr doi: 10.1017/S1041610208007734 contributor: fullname: EA Weamer |
SSID | ssj0014765 |
Score | 2.4542935 |
SecondaryResourceType | review_article |
Snippet | Psychotic symptoms occur in ∼40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional... Psychotic symptoms occur in ~40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional... Psychotic symptoms occur in similar to 40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased... Psychotic symptoms occur in approximately 40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased... Psychotic symptoms occur in approximately 40% of subjects with Alzheimer’s disease (AD) and are associated with more rapid cognitive decline and increased... |
SourceID | pubmedcentral hal proquest gale crossref pubmed pascalfrancis springer nature |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1316 |
SubjectTerms | 631/208/205/2138 631/378/1689/1761 692/699/375/132/1283 Adult and adolescent clinical studies Aged Aged, 80 and over Aging Alzheimer Disease - complications Alzheimer Disease - genetics Alzheimer Disease - psychology Alzheimer's disease Apolipoprotein E Apolipoproteins E - genetics Behavioral Sciences Biological and medical sciences Biological Psychology Bipolar disorder Case-Control Studies Chromosome 4 Chromosomes, Human, Pair 4 - genetics Cognitive ability Consortia Data processing Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Development and progression Disease DNA, Intergenic - genetics Family studies Female Gene mapping Genes Genetic aspects Genetic Predisposition to Disease - genetics Genetics Genome-wide association studies Genome-Wide Association Study - methods Genome-Wide Association Study - statistics & numerical data Genomes Genomics Glucose Transport Proteins, Facilitative - genetics Heritability Human health and pathology Humans Life Sciences Male Medical sciences Medicine Medicine & Public Health Mental disorders Mental health Middle Aged Neurocalcin - genetics Neurodegeneration Neurodegenerative diseases Neurology Neurosciences Organic mental disorders. Neuropsychology original-article Pharmacotherapy Physiological aspects Polymorphism, Single Nucleotide - genetics Proteins Psychiatric Status Rating Scales - statistics & numerical data Psychiatrics and mental health Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Psychosis Psychotic Disorders - complications Psychotic Disorders - diagnosis Psychotic Disorders - genetics Public health Single-nucleotide polymorphism |
Title | Genome-wide association study of Alzheimer's disease with psychotic symptoms |
URI | http://dx.doi.org/10.1038/mp.2011.125 https://link.springer.com/article/10.1038/mp.2011.125 https://www.ncbi.nlm.nih.gov/pubmed/22005930 https://www.proquest.com/docview/1178895446 https://www.proquest.com/docview/2645765577 https://search.proquest.com/docview/1257744838 https://www.proquest.com/docview/1273377027 https://hal.science/hal-00688561 https://pubmed.ncbi.nlm.nih.gov/PMC3272435 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdry2Awxr7rrQve6OiTqW3Zlvw0nNEsjBLGWCFvRpJlEpg_Vqcb3V-_O1lx6rX0JYbosOT70P0kne4IORaUxSULpFdK-EGP70kVRB4v8e6MTgHimyjfRTK_iL4u46XdcOtsWOV2TjQTddEo3CM_BccN0DiOGfvU_vKwahSertoSGnvkIAjBlYM-s-Ww4AoiZkpJBjTG004e2ft5PuWnVdun7wywRvYNj2Tn5b0VhkUOyTUft6IDlpV9rYu7wOjtmMr_DlaNv5o9JU8s0HSzXjOekQe6fk4e9qUnr1-Q8y-6birt_VkX2hU7Gbkm36zblG728-9Kryt9edK59hjHxV1b117cWiu3u67aTVN1L8nF7OzH57lnKyt4KknCjaf8QheyTKTmfqIKwXhZwrKU-zHXFDBXKmThR1KCswcPB2bKlYhlkXINHC10Ql-R_bqp9SFxpdBYQinkGpZmseKyFCzVaZIWAA2EVA453nI3b_sEGrk5-KY8r9ochZCDEBxygpzP0ayAf0rY2wHQCSaoyjMKOCXiAD4ccjSiBHNQo-YPILuhK8yePc_Oc_wPr8NwwIu_A4cc9qId6KoWR2IGMhkJe6AAJJOAQkXQ_1b6ubX3DlOmc57GsLa-s3mnvA55PzTjyDHErdbNVYdMACgeccrvo2GUMuaH8J7Xvb7txhea8oy-Q9hIE0esGLfU65VJKE5DFgJsdsjHrc7e-LLbsnpz_ye-JY-AMuxjfo7I_ubySr8D5LaRE2OeE3KQzabTBTynZ4tv3_8BPBJCvQ |
link.rule.ids | 230,314,780,784,885,12056,21388,27924,27925,31719,31720,33744,33745,43310,43805,73745,74302 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-xTggkhPgaC4wR0NCeoiVxEjtPqKCNAqVCaJP2FsWOo1ZaPrZ0oPHXc5e46cKmveShdmPn7uz72fcFsJcyHubck04u8UEa35HKCxyRU-yMjhHit16-s2hyEnw7DU_NhVtj3CpXe2K7UWeVojvyA1TcCI3DkPOP9blDVaPIumpKaGzAJmVOD0ew-elw9vNXb0cIeFtM0mMh2TtFYCL0XCYOirpL4OlRlexrOsnszBtzcozs02s-qtMGiZZ31S5ug6M3vSr_M622GuvoCTw2UNMed7LxFO7p8hnc74pPXj2H6RddVoV2_iwybadrLtltxlm7yu3x2d-5XhT6Yr-xjSHHpntb24RuLZTdXBX1siqaF3BydHj8eeKY2gqOiiJ_6Sg305nMI6mFG6ks5SLP8WCKNBSaIeqKU5m5gZSo7lHH4UIVKg1lFguNFM10xLZgVFal3gZbppqKKPlC4-EsVELmKY91HMUZgoNUKgv2VtRN6i6FRtKavplIijohJiTIBAv2ifIJLSykn0pNfAAOQimqkjFDpBIIhB8W7Ax64oJQg-b3yLt-KMqfPRlPE_qNAmIEIsbfngXbHWv7fkVNM2knsjtgdt8DsUyEAhXg-CvuJ2bFN5Q0XYg4xNP1rc1r8bXgXd9MMycnt1JXlw0RAcF4IJi4qw9njHPXx_e87ORtPT-_LdDoWsAHkjggxbClXMzblOLM5z4CZws-rGT22pfd5NWruz_xLTyYHP-YJtOvs--v4SH-y-88gHZgtLy41G8Qxy3lrlms_wDCUkP9 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD5inUBIE-I2FhgjoKE9RU3jJHaeUIGVAlU1ISbtLYodR61ELizd0Pj1nJO46cKmvfShdmvnXHw-59wADhPGg4yPpJNJ_CCL70g18h2RUe6MjhDiN1G-83B66n87C85M_FNtwirXZ2JzUKelonfkQzTcCI2DgPNhZsIiTj5PPlS_HeogRZ5W005jC7bRKrreALY_Hs9PfnQ-BZ83jSVHLCDfp_BNtp7LxDCv2mKeI-qYfc0-mVN6a0FBkl2pzZ0qqZGAWdv54jZoejPC8j83a2O9Jo_hkYGd9riVkydwTxdP4X7biPLqGcy-6KLMtfNnmWo72XDMbqrP2mVmj3_9Xehlrs-Pats4dWx6h2ubNK6lsuurvFqVef0cTifHPz9NHdNnwVFh6K0c5aY6lVkotXBDlSZcZBleUoUbCM0QgUWJTF1fSjT9aO9QaYVKAplGQiNFUx2yXRgUZaH3wJaJpoZKntB4UQuUkFnCIx2FUYpAIZHKgsM1deOqLacRN25wJuK8iokJMTLBgiOifExKhvRTickVwEWoXFU8ZohafIFQxIL93kxUDtUbfoe865aiWtrT8Sym7yg5RiB6vBxZsNeytpuXV7STZiMHPWZ3MxDXhChQPq6_5n5stL-mAupCRAHetG8d3oiyBW-7Ydo5BbwVuryoiQgIzH3BxF1zOGOcux7-z4tW3jb785pmja4FvCeJPVL0R4rloikvzjzuIYi24P1aZq892U1evbz7Ed_AA9TTePZ1_v0VPMQfeW0w0D4MVucX-jVCupU8MLr6DyVFSCo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genome-wide+association+study+of+Alzheimer%27s+disease+with+psychotic+symptoms&rft.jtitle=Molecular+psychiatry&rft.au=Hollingworth%2C+P&rft.au=Sweet%2C+R&rft.au=Sims%2C+R&rft.au=Harold%2C+D&rft.date=2012-12-01&rft.pub=Nature+Publishing+Group&rft.issn=1359-4184&rft.volume=17&rft.issue=12&rft.spage=1316&rft_id=info:doi/10.1038%2Fmp.2011.125&rft.externalDocID=A311048613 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon |